KR101499453B1 - Skin whitening composition comprising complex herbal extract - Google Patents

Skin whitening composition comprising complex herbal extract Download PDF

Info

Publication number
KR101499453B1
KR101499453B1 KR1020130053986A KR20130053986A KR101499453B1 KR 101499453 B1 KR101499453 B1 KR 101499453B1 KR 1020130053986 A KR1020130053986 A KR 1020130053986A KR 20130053986 A KR20130053986 A KR 20130053986A KR 101499453 B1 KR101499453 B1 KR 101499453B1
Authority
KR
South Korea
Prior art keywords
extract
acid
skin
activity
water
Prior art date
Application number
KR1020130053986A
Other languages
Korean (ko)
Other versions
KR20140134175A (en
Inventor
김세기
오종학
이슬기
정영주
손준호
박태순
김동희
황주영
Original Assignee
주식회사 이지함화장품
재단법인 한국한방산업진흥원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 이지함화장품, 재단법인 한국한방산업진흥원 filed Critical 주식회사 이지함화장품
Priority to KR1020130053986A priority Critical patent/KR101499453B1/en
Publication of KR20140134175A publication Critical patent/KR20140134175A/en
Application granted granted Critical
Publication of KR101499453B1 publication Critical patent/KR101499453B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/888Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Cosmetics (AREA)

Abstract

본 발명은 부평초 추출물을 유효성분으로 함유하는 조성물에 관한 것으로, 구체적으로 본 발명의 부평초 추출물은 항산화효과; 높은 세포 생존률; 미백활성; 주름개선효과 등을 확인하여 미백 및 피부노화 치료 및 예방용 조성물로 유용하게 이용될 수 있다.The present invention relates to a composition containing an extract of Buchungcho extract as an active ingredient. Specifically, the Buchungchwa extract of the present invention has an antioxidative effect; High cell viability; Whitening activity; Wrinkle-improving effect, etc., and can be usefully used as a composition for treating and preventing whitening and skin aging.

Description

부평초 추출물을 유효성분으로 함유하는 피부미백 및 피부노화 치료 및 예방용조성물 {Skin whitening composition comprising complex herbal extract}BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a composition for treating and preventing skin whitening and skin aging,

본 발명은 부평초 추출물을 유효성분으로 함유하는 피부미백 및 피부노화 치료 및 예방용 조성물에 관한 것이다.The present invention relates to a composition for treatment and prevention of skin whitening and skin aging, which comprises a Buchungchos extract as an active ingredient.

[문헌 1] Voegeli, R. 1996. Elastase and typtase determination on human skin surface. Cosmetic &Toiletries. 111, 51-58 [1] Voegeli, R. 1996. Elastase and typing determination on human skin surface. Cosmetic & Toiletries. 111, 51-58

[문헌 2] Aroca, P., et al. 1993. Melanin biosynthesis patterns of following hormonal stimulation. J. Biol Chem 268, 25650-25655 [Literature 2] Aroca, P., et al. 1993. Melanin biosynthesis patterns of following hormonal stimulation. J. Biol Chem 268, 25650-25655

[문헌 3] Jimenez-Cervantes C., et al. 1994. A new enzymatic function in the melanogenic pathway. J. Biol Chem 269, 17993-18001 [Literature 3] Jimenez-Cervantes C., et al. 1994. A new enzymatic function in the melanogenic pathway. J. Biol Chem 269, 17993-18001

[문헌 4] Paval, S. 1993. Dynamics of melanogenesis intermediates. J. Invest Dermatology 100, 162-165 [4] Paval, S. 1993. Dynamics of melanogenesis intermediates. J. Invest. Dermatology 100, 162-165

[문헌 5] Chin, J. E., et al. 2005. Effects of Houttuynia cordata extracts on tyrosinse gene expression. J. Korean Soc Food Sci Nutr 34, 1284-1288 [Literature 5] Chin, J. E., et al. 2005. Effects of Houttuynia cordata extracts on tyrosinase gene expression. J. Korean Soc Food Sci Nutr 34, 1284-1288

[문헌 6] Lee, P. J. 2009. Inhibitory effect of muscat bailey a seed extract on melanin production in α-MSH stimulated B16 cell. J. Kor Plant Res 22, 477-482 [Literature 6] Lee, P. J. 2009. Inhibitory effect of muscat bailey a seed extract on melanin production in α-MSH stimulated B16 cell. J. Kor Plant Res 22, 477-482

[문헌 7] Kim HK, Kim YE, Do JR, Lee YC, Lee BY. (1995) Antioxidative activity and hysiological activity of some Korean medicinal plants. J. Food Sci . Technol . 27, 80-86 [7] Kim HK, Kim YE, Do JR, Lee YC, Lee BY. (1995) Antioxidative activity and hysiological activity of some Korean medicinal plants. J. Food Sci . Technol . 27, 80-86

[문헌 8] Tsuji N, Moriwaki S, Suzuki Y, Takema Y and Imokawa G. (2001) The role of elastases secreted by fibroblasts in wrinkle formation: implication through selective inhibition of elastase activity. Photochem . Photobiol . 74(2), 283-290 [8] Tsuji N, Moriwaki S, Suzuki Y, Takema Y and Imokawa G. (2001) The role of elastases secreted by fibroblasts in wrinkle formation: implication through selective inhibition of elastase activity. Photochem . Photobiol . 74 (2), 283-290

[문헌 9] Roth GJ, Siok CJ and Ozols J. (1980) Structural characteristics of prostaglandin synthetase from sheep vesicular gland. J. Biol . Chem . 255(4), 1301-1304 [Literature 9] Roth GJ, Siok CJ and Ozols J. (1980) Structural characteristics of prostaglandin synthetase from sheep vesicular gland. J. Biol . Chem . 255 (4), 1301-1304

[문헌 10] A physiology active minuteness chemical technique development road map. (2002) Ministry of Commerce , Industry and Energy. 229-322 [Literature 10] A physiology active minuteness chemical technique development road map. (2002) Ministry of Commerce , Industry and Energy . 229-322

[문헌 11] Jeroma SP, Gabrielle L and Raul F. (1998) Identification of collagen fibrils in scleroderma skin. J. Invest . Dermatol. 90(1), 48-54 [11] Jeroma SP, Gabrielle L and Raul F. (1998) Identification of collagen fibrils in scleroderma skin. J. Invest . Dermatol . 90 (1), 48-54

[문헌 12] Oh KN. (2007) Protective effects of apigenin and luteolin on ultraviolet A- induced matrix metaaloproteinase expression in human keratinocyte. M. D. Thesis. Chosun university [Document 12] Oh KN. (2007) Protective effects of apigenin and luteolin on ultraviolet A-induced matrix metaaloproteinase expression in human keratinocyte. M. D. Thesis. Chosun university

[문헌 13] Carmichael J, DeGraff WG, Gazdar AF, Minna JD and Mitchell JB. (1987) Evaluation of a tetrazolium based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 47(4), 936-942 [Document 13] Carmichael J, DeGraff WG, Gazdar AF, Minna JD and Mitchell JB. (1987) Evaluation of a tetrazolium based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res . 47 (4), 936-942

[문헌 14] Prota G. (1980) Recent advances in the chemistry of melanogenesis in mammals. J. Invest Dermatol. 75(1), 122-127 [14] Prota G. (1980) Recent advances in the chemistry of melanogenesis in mammals. J. Invest Dermatol. 75 (1), 122-127

[문헌 15] Pavel S and Muskiet FA. (1983) Eumelanin (precursor) metabolites as markers for pigmented malignant melanoma, a preliminary report. Cancer Detect Prev . 6, 311-316 [Literature 15] Pavel S and Muskiet FA. (1983) Eumelanin (precursor) metabolites as markers for pigmented malignant melanoma, a preliminary report. Cancer Detect Prev . 6, 311-316

[문헌 16] Lee NH, Yang HC, Bu HJ, Jung DS, Lee SJ, Riu KZ. (2001) Screening of the tyrosinase inhibition and hyaluronidase inhibition activities and radical scavenging effects using plants in Cheju. Kor . J. Pharmacogn . 32(3), 175-180 [16] Lee, HC, Bu, HJ, Jung DS, Lee, SJ, Riu, KZ. (2001) Screening of the tyrosinase inhibitory and hyaluronidase inhibitory activities and radical scavenging effects using plants in Cheju. Kor . J. Pharmacogn . 32 (3), 175-180

[문헌 17] 정보섭 외 1인, 향약 대사전, 영림사, pp.277~278, 1998년).[Literature 17] Ipseong et al. 1, Encyclopedia of Contemplation, Young Lim, pp. 277 ~ 278, 1998).

[문헌 18] Suh, S. S. and Shin, J. S.: Studies on phytosterols, Yakhak HoeChi, 13, 144-146 (1969) Suh, SS and Shin, JS: Studies on phytosterols, Yakhak HoeChi , 13 , 144-146 (1969)

[문헌 19] Wallace, J. W.: Biosynthesic studies on flavones and C-glycosylflavones: B-ring oxidation patterns, Phytochemistry, 14, 1765-1768 (1975) [19] Wallace, J. W .: Biosynthesic studies on flavones and C-glycosylflavones: B-ring oxidation patterns, Phytochemistry, 14, 1765-1768 (1975)

[문헌 20] Harborne, J. B.: The natural distribution in angiosperms of anthocyanins acylated with aliphatic dicarboxylic acids, Phytochemistry, 25 (8), 1887-1894 (1981) [문헌 21] Woo, W. S., Lee, E. B. and Chang, I M.: Biological evaluation of Korean medicinal plants. Ⅱ., Kor. J. Pharm., 21, 177-183 (1977) [20] Harborne, JB: The natural distribution in angiosperms of anthocyanins acylated with aliphatic dicarboxylic acids, Phytochemistry, 25 (8), 1887-1894 (1981) .: Biological evaluation of Korean medicinal plants. II., Kor . J. Pharm ., 21 , 177-183 (1977)

[문헌 22] 우원식, 이은방: 적출장기표본에 의한 국산생약의 생리활성 검색 (Ⅱ), 생약학회지, 10 (1), 27-30 (1979) [Literature 22] Woo Sik Sik, Eunbang Lee: Detection of physiological activities of Korean herbal medicines by extracted long-term specimens (Ⅱ), Journal of Pharmacognosy, 10 (1), 27-30 (1979)

[문헌 23] 장일무, 지형준: 한국산 생약의 약리작용 및 독성연구 (제3보), 생약학회지, 13 (2), 55-61 (1982) [Literature 23] Jang, Myung-joo and Ji Hyung-joon: Studies on the pharmacokinetics and toxicity of Korean herbal medicines (3rd), Journal of Pharmacognosy, 13 (2), 55-61 (1982)

[문헌 24] Kim, C. J., Cho, S. K., Shin, M. S., Cho, H., Ro, D. S., Park, J. S. and Yook, C. S.: Hypoglycemic activity of medicinal plants, Arch. Pharm. Res., 13 (4), 371-373 (1990) [24] Kim, CJ, Cho, SK, Shin, MS, Cho, H., Ro, DS, Park, JS and Yook, CS: Hypoglycemic activity of medicinal plants, Arch . Pharm . Res ., 13 (4), 371-373 (1990)

[문헌 25] Blois MS. (1958) Antioxidant determination by the use of a stable free radical. 26, 1199-1120[Literature 25] Blois MS. (1958) Antioxidant determination by the use of a stable free radical. 26, 1199-1120

[문헌 26] Carmichael, J., W. G. DeGraff, A. F. Gazdar, J. D. Minna, and J. B. Mitchell. 1987. Evaluation of a tetrazolium based semiautomated colorimetric assay: assessment of chemosen- sitivity testing. Cancer Res . 47, 936-942. [26] Carmichael, J., WG DeGraff, AF Gazdar, JD Minna, and JB Mitchell. 1987. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res . 47 , 936-942.

[문헌 27] Cannell RJP, Kellan SJ, Owsianks AM and Walker JM. (1988) Results of a large scale screen of microalgae for the production of protease inhibitors. Planta Media. 54(1), 10-14.[Document 27] Cannell RJP, Kellan SJ, Owsians AM and Walker JM. (1988) Results of a large scale screen of microalgae for the production of protease inhibitors. Planta Media . 54 (1), 10-14.

[문헌 28] WE and Heindrich HG. (1963) Zur quantitativen bestimmung der collagenase. Hoppe-Seyler's. Physiol . Chem. 333:149-151 [Document 28] WE and Heindrich HG. (1963) Zur quantitativen bestimmung der collagenase. Hoppe-Seyler's. Physiol . Chem . 333: 149-151

[문헌 29] Kim MJ, Kim JY, Choi SW, Hong JT and Yoon KS. (2004) Anti-wrinkle effect of safflower (Cathamus tinctorius) seed extract. J. Soc . Cosmet . Scientisis Korea . 30(1), 15-22 [29] Kim MJ, Kim JY, Choi SW, Hong JT and Yoon KS. (2004) Anti-wrinkle effect of safflower ( Cathamus tinctorius ) seed extract. J. Soc . Cosmet . Scientisis Korea . 30 (1), 15-22

[문헌 30] Shim JS, Choi EJ, Lee CW, Kim HS and Hwang JK. (2009) Matrix metalloproteinase-1 inhibitory activity of Kaempferia pandurata Roxb. J of food. 12(3), 601-607 [Literature 30] Shim JS, Choi EJ, Lee CW, Kim HS and Hwang JK. (2009) Matrix metalloproteinase-1 inhibitory activity of Kaempferia pandurata Roxb. J of food . 12 (3), 601-607

[문헌 31] Yagi A, Kanbara T and Morinobu N. (1986) The effect of tyrosinase inhibition for aloe. Planta Media. 3981, 517-519[31] Yagi A, Kanbara T and Morinobu N. (1986) The effect of tyrosinase inhibition for aloe. Planta Media . 3981, 517-519

[문헌 32] Hosoi J. Abe E, Suda T and Kuroki T. (1985) Regulation of melanin synthesis of B16 mouse melanoma cells by 1 alpha, 25-dihydroxyvitamin D3 and retinoic acid. Cancer Res. 45(4), 1474-1478 [32] Hosoi J. Abe E, Suda T and Kuroki T. (1985) Regulation of melanin synthesis of B16 mouse melanoma cells by 1 alpha, 25-dihydroxyvitamin D3 and retinoic acid. Cancer Res . 45 (4), 1474-1478

[문헌 33] Choi BW, Lee BH, Kang KJ, Lee ES and Lee NH. (1998) Screening of the tyrosinase inhibitors from marine algae and medicinal plants. Kor . J. Pharmacogn. 29(3), 237-242
[Literature 33] Choi BW, Lee BH, Kang KJ, Lee ES and Lee NH. (1998) Screening of the tyrosinase inhibitors from marine algae and medicinal plants. Kor . J. Pharmacogn . 29 (3), 237-242

현대인들은 자외선, 스트레스 등의 여러 가지 내외적인 요인에 의해 각종 피부 트러블 유발로 기미, 주근깨, 피부 색소 침착 등의 피부 노화 현상을 촉진한다(Voegeli, R. 1996. Elastase and typtase determination on human skin surface. Cosmetic &Toiletries. 111, 51-58.). 피부의 색소 침착은 멜라닌 색소이 생합성에서 tyrosinase 효소를 비롯하여 DHICA oxidase(TRP-1)등의 L-tyrosine을 DOPA(3,4-dihydroxyphenyla-lanine)으로 DOPA에서 DOPA quinone으로 초기반응을 조절하는 것으로 알려져 있다(Aroca, P., et al. 1993. Melanin biosynthesis patterns of following hormonal stimulation. J. Biol Chem 268, 25650-25655.; Jimenez-Cervantes C., et al. 1994. A new enzymatic function in the melanogenic pathway. J. Biol Chem 269, 17993-18001.; Paval, S. 1993. Dynamics of melanogenesis intermediates. J. Invest Dermatology 100, 162-165.). 이를 바탕으로 티로시나제(tyrosinase) 효소의 활성을 저해하여 멜라닌 생합성의 억제에 영향을 미칠 수 있는 천연물 탐색에 대한 연구가 활발히 진행되고 있다. 그 결과 어성초 추출물을 이용하여 티로시나제(tyrosinase) 유전자 발현 억제 효과(Chin, J. E., et al. 2005. Effects of Houttuynia cordata extracts on tyrosinse gene expression. J. Korean Soc Food Sci Nutr 34, 1284-1288.), 머루 포도씨 추출물의 α-MSH으로 자극한 B16세포에서 멜라닌(melanin) 생성억제 효과(Lee, P. J. 2009. Inhibitory effect of muscat bailey a seed extract on melanin production in α-MSH stimulated B16 cell. J. Kor Plant Res 22, 477-482.) 등 천연물을 활용한 연구가 활발히 이뤄지고 있다. 그 외 현재 알려져 있는 항산화 및 미백원료는 아르부틴(Arbutin), 코지산(Kojic acid), 아스코르브산(Ascorbic acid) 등의 물질이 대표적이고 상백피, 닥나무, 감초 등의 식물 추출물이 널리 알려져 있다.Modern people promote skin aging phenomena such as spots, freckles and skin pigmentation by inducing various skin troubles due to various internal and external factors such as ultraviolet rays and stress (Voegeli, R. 1996. Elastase and typing determination on human skin surface. Cosmetic & Toiletries. 111, 51-58.). Pigmentation of the skin is known to regulate the initial reaction from DOPA to DOPA quinone with tyrosinase enzyme, L-tyrosine, such as DHICA oxidase (TRP-1), and DOPA (3,4-dihydroxyphenyla-lanine) in melanin pigment biosynthesis (Aroca, P., et al 1993. Melanin biosynthesis patterns of the following hormonal stimulation: J. Biol Chem 268, 25650-25655 .; Jimenez-Cervantes C., et al 1994. A new enzymatic function in the melanogenic pathway. J. Biol Chem 269, 17993-18001; Paval, S. 1993. Dynamics of melanogenesis intermediates, J. Invest. Dermatology 100, 162-165.). On the basis of this, studies on the search for natural products that inhibit the activity of tyrosinase enzyme and affect the inhibition of melanin biosynthesis are actively conducted. As a result, the tyrosinase gene expression inhibitory effect of horsetail extract (Chin, JE, et al., 2005. Effects of Houttuynia cordata extracts on tyrosinase gene expression, J. Korean Soc Food Sci Nutr 34, 1284-1288) Inhibitory effect of α-MSH-stimulated melanin on the production of melanin in B16 cells (Lee, PJ 2009. Inhibitory effect of muscat bailey a seed extract on melanin production in α-MSH stimulated B16 cell. J. Kor Plant Res. 22, 477-482.) Are being actively studied. Other known antioxidative and whitening raw materials are Arbutin, Kojic acid, Ascorbic acid, etc. Plant extracts such as bark, mackerel and licorice are widely known.

DPPH는 화학적으로 안정화된 자유 라디칼 (free radical)을 가지고 있는 수용성 물질로 ascorbic acid, tocopherol, polyhydroxy 방향족 화합물 등에 의해 환원되어 짙은 자색이 탈색되는데, 이것은 다양한 천연 소재로부터 항산화 물질을 검색하는데 많이 이용되고 있다. ROS (reactive oxygen species)는 체내 방어기전에 의해 대부분 제거되지만 제거되지 못할 경우 생체분자들과 신속하게 반응하여 단백질의 변성이나 생체막의 지질 과산화, DNA 손상 등을 일으키며, 세포 내로 확산되거나 혈류를 통해 이동된 지질 과산화물은 새로운 radical 반응을 촉진시켜 각종 질환의 원인으로 작용하였다. (Kim HK, Kim YE, Do JR, Lee YC, Lee BY. (1995) Antioxidative activity and hysiological activity of some Korean medicinal plants. J. Food Sci . Technol . 27, 80-86)DPPH is a chemically stabilized water-soluble substance with free radicals, which is reduced by ascorbic acid, tocopherol, and polyhydroxy aromatic compounds, resulting in discoloration of deep purple color, which is widely used to search for antioxidants from various natural materials . Reactive oxygen species (ROS) are largely eliminated by the body's defense system, but if not eliminated, they react with biomolecules rapidly to cause protein denaturation, lipid peroxidation and DNA damage of the biological membrane, Lipid peroxides promoted new radical reactions and acted as a cause of various diseases. (1995) Antioxidative activity and hysiological activity of some Korean medicinal plants J. Food (Kim HK, Kim YE, Do JR, Lee YC, Lee BY. Sci . Technol . 27, 80-86)

Elastase는 진피 내 피부탄력을 유지시키는 데 중요한 기질인 엘라스틴을 분해하는 효소이다. 또한 elastase는 다른 중요한 기질단백질인 collagen을 분해할 수 있는 비특이적 가수분해 효소이다. 따라서 elastase 저해제는 피부주름을 개선하는 작용을 나타내며, ursolic acid 등이 elastase 저해제로서 이용되고 있다. Elastase는 동물 결합조직의 불용성 탄성 섬유 단백질인 elastin을 분해시켜 피부의 진피조기의 그물망 구조 결합을 끊어줌으로서 주름생성의 주원인인 효소로 알려져 있다.(Tsuji N, Moriwaki S, Suzuki Y, Takema Y and Imokawa G. (2001) The role of elastases secreted by fibroblasts in wrinkle formation: implication through selective inhibition of elastase activity. Photochem . Photobiol . 74(2), 283-290) 피부의 진피 조직 속에는 collagen과 피부의 탄력성에 관련된 elastin이 그물망 구조를 형성하고 있는데, 이러한 그물망 구조가 깨어지면서 즉 elastin이 elastase에 의해 분해되어 피부가 처지고 주름이 생기므로 내인성 피부노화가 발생한다. 그러므로 피부노화의 주원인 중의 하나인 elastin 분해효소인 elastase의 활성을 저하시킴으로서 피부노화를 억제할 수 있다. 현재 피부노화를 방지하려는 연구가 활발히 진행되고 있으며 지금까지 α-1-proteinase inhibitor, mucus proteinase inhibitor, α-2-macri globulin, inter-α-trypsin, bowman-birk inhibitor, verapamil, beta lactam, chondroitin sulfates, deoxycycline, heparin등의 elastase 저해제들이 보고되고 있다. (Roth GJ, Siok CJ and Ozols J. (1980) Structural characteristics of prostaglandin synthetase from sheep vesicular gland. J. Biol. Chem . 255(4), 1301-1304)Elastase is an enzyme that degrades elastin, an important substrate for maintaining skin elasticity in the dermis. Elastase is also a nonspecific hydrolytic enzyme capable of degrading collagen, another important substrate protein. Thus, the elastase inhibitor has the function of improving the wrinkles of the skin, and ursolic acid has been used as the elastase inhibitor. Elastase is known to be the main enzyme of wrinkle formation by decomposing elastin, the insoluble elastic fiber protein of animal connective tissues, and breaking the network structure of the dermis early in the dermis (Tsuji N, Moriwaki S, Imokawa G. (2001) the role of elastases secreted by fibroblasts in wrinkle formation:... implication through selective inhibition of elastase activity Photochem Photobiol 74 (2), 283-290) ln dermal tissues of the skin associated with collagen and elasticity of the skin elastin forms a network structure. As the network structure is broken, that is, the elastin is decomposed by elastase, the skin is sagged and wrinkles are generated, so that the endogenous skin aging occurs. Therefore, skin aging can be suppressed by lowering the activity of elastase, elastin degrading enzyme, which is one of the major causes of skin aging. Currently, studies to prevent skin aging have been actively conducted, and up to now, there have been many studies on α-1-proteinase inhibitor, mucus proteinase inhibitor, α-2-macri globulin, inter-α-trypsin, bowman-birk inhibitor, verapamil, beta lactam, chondroitin sulfates , deoxycycline, heparin, and other elastase inhibitors have been reported. (Roth GJ, Siok CJ and Ozols J. (1980) Structural characteristics of prostaglandin synthetase from sheep vesicular gland. J. Biol. Chem . 255 (4), 1301-1304)

세포 외 기질(extracellular matrix)의 주요 구성 성분인 collagen은 피부의 섬유아세포에서 생성되는 주요 기질 단백질이다. 또한 생체 단백질 총 중량의 약 30%를 차지하는 중요한 단백질로서 견고한 3중 나선구조를 가지고 있다. Collagen은 피부, 건(tendon), 뼈 및 치아의 유기 물질의 대부분을 형성하는데, 특히 뼈와 피부의 진피에 그 포함량이 높다. Collagen의 주된 기능으로는 피부의 기계적 견고성, 결합조직의 저항력과 조직의 결합력, 세포 접착의 지탱, 세포 분할과 분화의 유도 등이 알려져 있다. 이러한 collagen은 연령 및 자외선 조사에 의한 광노화에 의해 감소하며, 이는 피부의 주름 형성과 밀접한 연관이 있다고 알려져 있다. 또한 collagen은 트립신 등의 단백질 분해효소의 작용을 받지 않으나, collagenase에 의해 분해된다는 보고된 바 있다 (A physiology active minuteness chemical technique development road map. (2002) Ministry of Commerce , Industry and Energy. 229-322)Collagen, a major component of the extracellular matrix, is a major substrate protein produced by the fibroblasts of the skin. It is also an important protein that accounts for about 30% of the total biomass protein weight, and has a solid triple helix structure. Collagen forms most of the organic matter in the skin, tendons, bones and teeth, especially in the bones and dermis of the skin. The main functions of collagen are known to be mechanical rigidity of skin, resistance of connective tissues and binding force of tissues, support of cell adhesion, induction of cell division and differentiation. Such collagen is reduced by aging and photoaging by ultraviolet irradiation, which is known to be closely related to wrinkling of the skin. In addition, collagen is not affected by proteases such as trypsin but is degraded by collagenase (A physiology active minuteness chemical technique development road map. (2002) Ministry of Commerce , Industry and Energy . 229-322)

콜라겐은 대부분 피부의 진피층에 존재하며, 피부 전체 건조중량의 약 70~80%를 차지하고 있어, 세포외 기질의 대부분을 차지하면서 피부를 지지하는 역할을 한다. 그러나 자연 노화에 따른 세포 활성의 감소와 같은 내적 요인에 의해 콜라겐의 생합성이 감소되고, 여러 가지 유해 환경에 의한 스트레스의 증가 및 태양 광선에 의한 활성 산소종의 증가와 같은 외적 요인에 의해 분해가 가속화 되어 피부 기질이 파괴되면서 주름이 생성된다. 또한 collagen은 상처 치유에 있어서 중요한 역할을 담당하며, 손상된 상피에서 collagen의 합성을 촉진시키면서 상처를 신속하게 흉터 없이 회복할 수 있다. 현재까지 밝혀진 collagen 합성 촉진 물질 중 가장 대표적인 것으로는 centella asiatica의 주성분들인 asiaticoside, asiatic acid, madecasic acid 등을 들 수 있다. (Jeroma SP, Gabrielle L and Raul F. (1998) Identification of collagen fibrils in scleroderma skin. J. Invest . Dermatol. 90(1), 48-54)Most of the collagen is present in the dermis of the skin and accounts for about 70 to 80% of the dry weight of the skin. It plays a role of supporting the skin occupying most of the extracellular matrix. However, degradation of collagen is accelerated by extrinsic factors such as decrease of collagen biosynthesis due to internal factors such as decrease of cell activity due to natural aging, increase of stress due to various harmful environments, and increase of active oxygen species by sunlight And the skin substrate is destroyed to form wrinkles. In addition, collagen plays an important role in wound healing and can quickly restore scarring without promoting the synthesis of collagen in damaged epithelium. The most prominent collagen synthesis promoters that have been identified so far include asiaticoside, asiatic acid, and madecasic acid, the major components of centella asiatica. (Jeroma SP, Gabrielle L and Raul F. (1998) Identification of collagen fibrils in scleroderma skin J. Invest . Dermatol . 90 (1), 48-54)

체내에서 생성되는 수종의 MMPs 가운데 MMP-1은 콜라겐에 특이적으로 작용하는 protease로서 MMP-1의 활성을 억제하여 콜라겐의 분해를 감소시키면, 피부조직의 탄력을 유지하고 주름생성을 예방할 수 있는 것으로 알려져 있다. (Oh KN. (2007) Protective effects of apigenin and luteolin on ultraviolet A- induced matrix metaaloproteinase expression in human keratinocyte. M. D. Thesis. Chosun university) Among several kinds of MMPs produced in the body, MMP-1 is a collagen-specific protease that inhibits the activity of MMP-1 to reduce collagen degradation, thereby maintaining skin elasticity and preventing wrinkle formation It is known. (Oh KN. (2007) Protective effects of apigenin and luteolin on ultraviolet A-induced matrix metaaloproteinase expression in human keratinocyte M. D. Thesis.

MTT 검색법은 96 well plate를 사용하여 검사 결과를 ELISA reader를 이용하여 많은 시료를 간단하게 판독할 수 있어 세포 독성 및 세포 증식 검색법으로 널리 사용되고 있으며, 세포의 대사과정에서 미토콘드리아의 탈수소 효소 작용에 의해 노란색 수용성 MTT tetrazolium을 자주색을 띠는 비수용성의 MTT formazan으로 환원시키는 방법이다.(Carmichael J, DeGraff WG, Gazdar AF, Minna JD and Mitchell JB. (1987) Evaluation of a tetrazolium based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 47(4), 936-942.)MTT detection method is widely used as a cytotoxicity and cell proliferation detection method because many samples can be easily read using an ELISA reader using a 96-well plate, and the dehydrogenase activity of mitochondria in cell metabolism (1987), a yellow-soluble MTT tetrazolium is reduced to a purple, water-insoluble MTT formazan. (Carmichael J, DeGraff WG, and Gazdar AF, of chemosensitivity testing. Cancer Res . 47 (4), 936-942.)

피부의 색조를 결정하는 주요한 인자인 melanin은 표피 기저층의 melanocyte라고 불리는 색소세포내의 melanosome에서 생합성 된다. 멜라닌을 합성하는데 있어서의 출발물질은 아미노산의 일종인 tyrosine이다. Tyrosine은 멜라닌 세포내에서의 tyrosinase에 의해 L-3,4-dihydroxyl phenylalanine (DOPA), DOPA quinone으로 산화된다. 그 후 DOPA quinone이 DOPA chrome, 5,6-dihydroxyindole, indole-5,6-quinone이 되고, 이어서 indole-5,6-quinone으로의 중합에 의해 melanin을 생성하는 것으로 알려져 있다. 또한 tyrosinase는 피부 멜라닌 생성에 있어서 매우 중요한 역할을 하고 있으며, melanosome 내에서 tyrosine을 산화시켜 DOPA를 만드는 tyrosine hydoxylase로, DOPA를 산화시켜 DOPA quinone을 만드는 DOPA oxidase로서 작용하여 멜라닌 중합체를 합성하는데 중요한 효소로 작용한다.(Prota G. (1980) Recent advances in the chemistry of melanogenesis in mammals. J. Invest Dermatol . 75(1), 122-127.)Melanin, a key determinant of skin tone, is biosynthesized in melanosomes in pigmented cells called melanocytes in the epidermal basal layer. The starting material for the synthesis of melanin is tyrosine, an amino acid. Tyrosine is oxidized by tyrosinase in melanocytes to L-3,4-dihydroxyl phenylalanine (DOPA) and DOPA quinone. It is known that DOPA quinone then becomes DOPA chrome, 5,6-dihydroxyindole, and indole-5,6-quinone, and then melanin is formed by polymerization with indole-5,6-quinone. In addition, tyrosinase plays an important role in the formation of melanin in the skin. Tyrosine hydoxylase, which oxidizes tyrosine in melanosome to form DOPA, acts as a DOPA oxidase that oxidizes DOPA to form DOPA quinone. (Prota G. (1980) Recent advances in the chemistry of melanogenesis in mammals J. Invest Dermatol . 75 (1), 122-127.)

사람의 피부색을 결정하는 가장 중요한 요인인 멜라닌(melanin)은 피부의 광노화나 일광각화증을 억제할 뿐만 아니라, 기미, 주근깨, 검버섯 등의 부분적인 hyperpigmentation을 일으키는 역할을 하고 있다. 상기의 색소 침착을 치유하기 위해 멜라닌 생성을 억제하는 hydroquinone, resorcinol 등의 페놀 유도체나, L-ascorbic acid와 그 유도체 및 kojic acid, arbutin, lactic acid, glucosamine, tunicamycin 등이 개발되었으나, 피부 저자극성이나 안정성에 문제가 있어 극히 제한된 양만 사용되고 있다. (Pavel S and Muskiet FA. (1983) Eumelanin (precursor) metabolites as markers for pigmented malignant melanoma, a preliminary report. Cancer Detect Prev . 6, 311-316.).
Melanin, which is the most important factor in determining human skin color, not only inhibits skin photoaging and sunburn keratosis but also causes partial hyperpigmentation of spots, freckles, and black spots. L-ascorbic acid and its derivatives and kojic acid, arbutin, lactic acid, glucosamine, and tunicamycin have been developed to inhibit melanogenesis. There is a problem with stability and only a very limited amount is used. (Pavel S and Muskiet FA. (1983) Eumelanin (precursor) metabolites as markers for pigmented malignant melanoma, a preliminary report. Cancer Detect Prev . 6, 311-316.).

피부 흑화는 피부에 존재하는 melanocyte가 UV 노출 등의 외부적 환경에 대응하여 melanin의 생성을 증가하기 때문이다. 원료 및 물질의 미백효능을 확인하기 위해 melanin 생성효소인 Tyrosinase의 효소활성 억제 탐색이 주요하게 이용되어 왔으나 최근 효소활성억제와 더불어 미백원료가 melanocyte에서 tyrosinase와 관련 효소 발현을 증가시키는 환경에서 신호전달 체계를 교란시키는 기전 연구에 대한 보고가 매우 많아졌다. (Lee NH, Yang HC, Bu HJ, Jung DS, Lee SJ, Riu KZ. (2001) Screening of the tyrosinase inhibition and hyaluronidase inhibition activities and radical scavenging effects using plants in Cheju. Kor . J. Pharmacogn . 32(3), 175-180.).
Skin blackening is due to the fact that melanocytes present in the skin increase the production of melanin in response to external conditions such as UV exposure. In order to confirm the whitening effect of raw materials and substances, the inhibition of enzyme activity of tyrosinase, which is a melanin-producing enzyme, has been mainly used. However, in recent years, in addition to suppression of enzyme activity, whitening agents have been shown to increase tyrosinase and related enzyme expression in melanocyte There have been many reports on the mechanism studies that disturb (. Lee NH, Yang HC, Bu HJ, Jung DS, Lee SJ, Riu KZ (2001) Screening of the tyrosinase inhibition and hyaluronidase inhibition activities and radical scavenging effects using plants in Cheju. Kor. J. Pharmacogn. 32 (3) , 175-180.).

부평초(Spirodela polyrrhiza)는 천남성과의 다년생 초본으로서 수면에 뜨는 작은 풀로서 개구리밥에 전초를 부평초라고도 지칭하며, 산화칼륨 및 염화칼륨, 불소 등의 성분이 알려져 있고 강심작용, 해혈작용 등에 효과가 있는 것으로 알려진바 있다.(정보섭 외 1인, 향약 대사전, 영림사, pp.277~278, 1998년). Spirodela polyrrhiza ) is a perennial herbaceous plant of the genus Sennaeus . It is a small grass floating on the surface of the water. It is also known as a fowlpowder, and its components such as potassium oxide, potassium chloride and fluorine are known to be effective for arteriosclerosis and hematopoiesis. (1) (1). (2).

浮萍草 (부평초)의 성분 연구로는 개구리밥의 全草 (전초)에서 campesterol, β-sitosterol, stigmasterol 등의 sterol(4. Suh, S. S. and Shin, J. S.: Studies on phytosterols, Yakhak HoeChi, 13, 144-146 (1969)과, flavone-O-glycoside로서 apigenin-7-O-β-D-glucoside, cynaroside (luteolin-7-O-β-D-glucoside), hypolaetin-8-O-β-D-glucoside (8-hydroxyluteolin-8-O-β-D-glucoside)와, flavone-C-glycoside로서 vitexin (apigenin-8-C-β-D-glucoside), orientin (luteolin-8-C-β-D-glucoside) 등의 flavonoid(5. Wallace, J. W.: Biosynthesic studies on flavones and C-glycosylflavones: B-ring oxidation patterns, Phytochemistry, 14, 1765-1768 (1975) 및 anthocyanin(6. Harborne, J. B.: The natural distribution in angiosperms of anthocyanins acylated with aliphatic dicarboxylic acids, Phytochemistry, 25 (8), 1887-1894 (1981)이 존재한다고 알려져 있다.Studies on the constituents of 浮萍 草 (Puchipcheon) showed that all the grasses (outposts) of the frog were treated with sterols such as campesterol, β-sitosterol and stigmasterol (4. Suh, SS and Shin, JS: Studies on phytosterols, Yakhak HoeChi, 13, 144-146 (1969) and, flavone-O-glycoside as apigenin-7-O-β- D-glucoside, cynaroside (luteolin-7-O-β-D-glucoside), hypolaetin-8-O (8-hydroxylase-8-O-β-D-glucoside) and flavone-C-glycoside as vitexin (apigenin-8-C-β-D-glucoside), orientin B-ring oxidation patterns, Phytochemistry , 14 , 1765-1768 (1975) and anthocyanin (6. Harborne, JW: Biosynthesic studies on flavones and C-glycosylflavones: JB: The natural distribution in angiosperms of anthocyanins acylated with aliphatic dicarboxylic acids, Phytochemistry , 25 (8), 1887-1894 (1981).

한편 浮萍草 (부평초)의 생리활성 연구로는 1977년 Woo등(7. Woo, W. S., Lee, E. B. and Chang, I M.: Biological evaluation of Korean medicinal plants. Ⅱ., Kor. J. Pharm., 21, 177-183 (1977)의 실험에서 개구리밥 EtOH (defatted with pet ether) 추출물이 sarcoma 180, leukemia SN 36, Ehrlich ascites carcinoma에 대한 항암작용, HeLa cell에 대한 세포독성작용, Staphylococcus aureus와 Escherichia coli에 대한 항미생물작용이 모두 없었고, 1979년 개구리밥 MeOH 추출물로 한 실험에서는 rat의 회장절편에 대해 직접적인 수축작용이나 항acetylcholine작용이 없었으며, 자궁절편에 대해서도 직접적인 수축작용이나 항oxytocin작용이 없었다.(우원식, 이은방: 적출장기표본에 의한 국산생약의 생리활성 검색 (Ⅱ), 생약학회지, 10 (1), 27-30 (1979).1982년에 장 등(9. 장일무, 지형준: 한국산 생약의 약리작용 및 독성연구 (제3보), 생약학회지, 13 (2), 55-61 (1982)이 한 실험에서 개구리밥 EtOH 추출물이 neuroglioma 9ASK에 대해 약한 항유사분열작용을 보였으나 세포독성작용은 나타나지 않았고, CHCl3 분획의 추출물은 leukemia P388에 대해 항암작용이 없다고 보고하였고, 1990년 Ro 등 (10. Kim, C. J., Cho, S. K., Shin, M. S., Cho, H., Ro, D. S., Park, J. S. and Yook, C. S.: Hypoglycemic activity of medicinal plants, Arch. Pharm. Res., 13 (4), 371-373 (1990)은 개구리밥의 물 추출물이 streptozotocin에 의해 유발된 당뇨병 mouse에서 항과혈당작용이 없음을 보고된 바 있다.
In a study of bioactive浮萍草(bupyeongcho) are 1977 Woo, etc. (7.. Woo, WS, Lee , EB and Chang, I M .: Biological evaluation of Korean medicinal plants. Ⅱ, Kor. J. Pharm. , 21 , 177-183 (1977), the antitumor activity against sarcoma 180, leukemia SN 36 and Ehrlich ascites carcinoma, the cytotoxic action against HeLa cell, the effect of Staphylococcus aureus and Escherichia coli . In 1979, the MeOH extract of Fried Rice showed no direct shrinkage or anti-acetylcholine action on the ileal section of the rat, and no direct contraction or anti-oxytocin action on the uterine segment. woowonsik, yieunbang: extraction Journal of biologically active search (ⅱ), domestic herbal herbal medicine due to the long-term sample, 10 (1), 27-30 in Chapter (1979) .1982 years, etc. (9 jangilmu, jihyeongjun: Pharmacology of Korean herbal (3), Journal of the Korean Pharmacopoeia, 13 (2), 55-61 (1982). In this experiment, the foliar EtOH extract showed weak anti-mitotic activity against neuroglioma 9ASK but no cytotoxic effect, and the extract of CHCl 3 fraction had anticancer activity against leukemia P388 (1990), Ro et al. (10) Kim, CJ, Cho, SK, Shin, MS, Cho, H., Ro, DS, Park, JS and Yook, CS: Hypoglycemic activity of medicinal plants, Arch Pharm . Res ., 13 (4), 371-373 (1990) have reported that water extract of frogs does not have anti-glycemic effect in streptozotocin-induced diabetic mice.

그러나 상기 문헌의 어디에도 부평초 추출물의 미백, 주름개선 등의 피부노화에 대한 치료효과에 대하여 언급 또는 개시된 바는 없다. However, none of the above documents mentions or discloses the therapeutic effect on skin aging, such as whitening, wrinkle improvement, etc. of Puccio extract.

이에 본 발명자들은 부평초 추출물에 대하여 DPPH 자유 라디칼 소거활성, ABTS 라디칼 양이온 소거능 저해활성, 크산틴 옥시다제(Xanthine oxidase) 저해활성 등의 항산화효과; 높은 세포 생존률; 티로시나제 (Tyrosinase) 저해활성, 세포내 티로시나제(Cellular tyrosinase) 저해활성 멜라닌(melanin) 생합성 저해 활성, 미백과 관계되어진 티로시나제(tyrosinase) 단백질 발현억제 등의 미백활성; 엘라스타제 (Elastase) 저해활성, MMP-1저해활성, 프로-콜라게나제(pro-collagenase) 저해활성 실험을 통한 주름개선효과 등을 확인하여 미백 및 피부노화 치료 및 예방용 조성물로 유용함을 확인함으로써 본 발명을 완성하였다.
Accordingly, the present inventors have found that the antioxidative effects of the Puchoncho extracts such as DPPH free radical scavenging activity, ABTS radical scavenging activity inhibiting activity, and xanthine oxidase inhibiting activity; High cell viability; Tyrosinase inhibitory activity, Cellular tyrosinase Inhibitory activity Melanin inhibitory activity, whitening activity such as inhibition of tyrosinase protein expression associated with whitening; It was confirmed that it is useful as a composition for treating and preventing whitening and skin aging by confirming the effect of inhibiting elastase, MMP-1 inhibitory activity and pro-collagenase inhibitory activity Thereby completing the present invention.

상기 목적을 달성하기 위하여, 본 발명은 부평초 추출물을 유효성분으로 함유하는 미백 및 피부노화의 치료 및 예방용 피부외용 약학조성물을 제공한다.In order to achieve the above object, the present invention provides an external dermatological pharmaceutical composition for treating and preventing whitening and skin aging, which comprises an extract of Buchungcho extract as an active ingredient.

또한, 본 발명은 부평초 추출물을 유효성분으로 함유하는 미백 및 피부노화의 개선 및 예방용 화장료 조성물을 제공한다.The present invention also provides a cosmetic composition for improving and preventing whitening and aging of skin, which contains an extract of Buchungcho as an active ingredient.

본원에서 정의되는 추출물은 조추출물, 또는 분획 추출물을 포함한다.Extracts as defined herein include crude extracts, or fractionated extracts.

본원에서 정의되는“조추출물”은 물, 에탄올, 메탄올, 프로판올, 부탄올, 아세톤, 에틸아세테이트, 헥산, 부틸렌글리콜, 프로필렌글리콜, 함수부틸렌글리콜, 함수프로필렌글리콜, 함수글리세린으로 구성된 그룹으로부터 선택된 하나 이상의 용매, 바람직하게는 물 또는 물 및 에탄올 혼합용매, 가장 바람직하게는 60% 내지 80% 에탄올 가용 추출물을 포함한다.
As used herein, the term " crude extract " refers to water, ethanol, methanol, propanol, butanol, acetone, ethyl acetate, hexane, butylene glycol, propylene glycol, hydrolyzed butylene glycol, Or more, preferably water or a mixed solvent of water and ethanol, most preferably 60% to 80% ethanol-soluble extract.

본원에서 정의되는 분획 추출물은 비극성용매 가용 분획 추출물 및 극성용매 가용 분획 추출물을 포함한다.The fraction extracts defined herein include nonpolar solvent soluble fraction extracts and polar solvent soluble fraction extracts.

본원에서 정의되는 비극성용매 가용 분획 추출물은 상기 조주출물을 물로 현탁한 후에 헥산, 메틸렌틀로리드, 디클로로메탄, 클로로포름 또는 에틸 아세테이트로부터 선택된 비극성용매로, 바람직하게는 헥산, 메틸렌 클로라이드 분획, 또는 에틸 아세테이트, 보다 바람직하게는 메틸렌클로리드 비극성 유기용매로 분획하여 얻은 비극성용매에 가용한 분획 추출물을 포함하고; 극성용매 가용 분획 추출물은 상기 비극성용매 가용정제물을 제거하고 남은 조추출물을 부탄올 또는 물로 분획을 수행하여 얻은 극성용매에 가용한 분획 추출물을 포함한다.The nonpolar solvent soluble fraction extract as defined herein is prepared by suspending the crude extract in water followed by treatment with a nonpolar solvent selected from hexane, methylene chloride, dichloromethane, chloroform or ethyl acetate, preferably hexane, methylene chloride fraction, or ethyl acetate , More preferably a fraction extract which is soluble in a non-polar solvent obtained by fractionation with a methylene chloride nonpolar organic solvent; The polar solvent-soluble fraction extract includes a fraction extract obtained by removing the nonpolar solvent-soluble tablet and allowing the remaining crude extract to be fractionated with butanol or water.

본원에서 정의되는 추출물은 조추출물 또는 비극성용매 가용 추출물을 포함하며 하기와 같은 제조공정으로 제조가능하다.
The extracts defined herein include crude extracts or non-polar solvent soluble extracts and can be prepared by the following process.

예를 들어, 본원발명의 조추출물은 시료 총 중량의 약 1배 내지 200배(w/w), 바람직하게는 10배 내지 100배(w/w)의 정제수를 포함한 물, 주정, 탄소수 1 내지 4의 저급 알콜 또는 이들의 혼합용매, 바람직하게는 물 또는 물 및 에탄올 혼합용매, 보다 바람직하게는 물 또는 50-99% 물 및 에탄올 혼합용매를 가하여 2시간 내지 1주일, 바람직하게는 4시간 내지 24시간 동안, 10℃ 내지 150℃, 바람직하게는 20℃ 내지 100℃, 보다 바람직하게는 실온에서 냉침추출, 열수추출, 초음파 추출, 환류냉각 추출 등의 추출방법, 바람직하게는, 환류냉각 추출법을 수행하여 추출물을 수득하는 제 1단계 공정을 통하여 수득가능하다.For example, the crude extract of the present invention may contain water, alcohol, water, and water containing about 1 to 200 times (w / w) of the total weight of the sample, preferably 10 to 100 times (w / 4 or a mixed solvent thereof, preferably water or a mixture of water and ethanol, more preferably water or a mixed solvent of 50-99% water and ethanol, for 2 hours to 1 week, preferably 4 hours to 1 week, The extraction method such as cold extraction, hot water extraction, ultrasonic extraction and reflux cooling extraction, preferably reflux cooling extraction method, at room temperature for 10 to 150 ° C, preferably 20 to 100 ° C, Followed by a first step of obtaining an extract.

예를 들어, 본원발명의 비극성용매 및 극성용매 가용 추출물은 상기에서 얻은 조추출물, 바람직하게는 60 내지 90% 에탄올 조추출물 중량의 약 0.0005 내지 50배, 바람직하게는 0.05 내지 5배 부피 (v/w%)의 물을 가한 후, n-헥산, 메틸렌 클로라이드, 에틸 아세테이트 및 부탄올을 이용한 통상적인 분획과정을 수행하여 n-헥산, 메틸렌 클로라이드, 에틸 아세테이트 등의 비극성 용매에 가용한 비극성 용매 가용 추출 정제물; 및 부탄올, 물 등의 극성용매에 가용한 극성용매 가용 추출 정제물을 각각 수득할 수 있다.
For example, the non-polar solvent and polar solvent-soluble extract of the present invention may be used in an amount of about 0.0005 to 50 times, preferably 0.05 to 5 times (v / v) of the crude extract, preferably 60 to 90% w%) of water, followed by a conventional fractionation process using n-hexane, methylene chloride, ethyl acetate and butanol to obtain nonpolar solvent-soluble extraction tablets (n-hexane, water; And a polar solvent-soluble extracted and purified product soluble in polar solvents such as butanol and water.

본원에서 정의되는 "피부노화"는 주름살, 기미, 주근께, 자외선에 의한 피부 손상, 피부암, 바람직하게는, 주름살 또는 기미를 포함한다.As defined herein, "skin aging" includes wrinkles, stains, muscle wounds, skin damage due to ultraviolet light, skin cancer, and preferably wrinkles or stains.

상기 부평초 추출물은 피부외용 약학조성물은 총 중량에 대하여 0.1 내지 50 중량%으로 포함함을 특징으로 한다.The suppuryecho extract comprises 0.1 to 50% by weight based on the total weight of the skin pharmaceutical composition.

상기 피부외용 약학 조성물은 크림, 젤, 패취, 분무제, 연고제, 경고제, 로션제, 리니멘트제, 파스타제 또는 카타플라스마제 제형을 포함한다. The dermatological pharmaceutical composition includes a cream, a gel, a patch, a spray, an ointment, a warning agent, a lotion, a liniment, a pasta agent or a cataplasma formulation.

또한, 상기 화장료 조성물은 화장수, 스킨, 로션, 영양로션, 영양크림, 마사지 크림, 에센스, 팩의 제형을 포함한다.
In addition, the cosmetic composition includes formulations of lotion, skin, lotion, nutrition lotion, nutritional cream, massage cream, essence, and pack.

이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.

본 발명의 부평초 추출물은 하기와 같이 수득될 수 있다.The Pucciola extract of the present invention can be obtained as follows.

본 발명의 건조상태의 부평초 중량의 약 1 내지 30배, 바람직하게는 약 1 내지 15배에 달하는 부피의 물, 에탄올, 메탄올, 프로판올, 부탄올, 아세톤, 에틸아세테이트, 헥산, 부틸렌글리콜, 프로필렌글리콜, 함수부틸렌글리콜, 함수프로필렌글리콜, 함수글리세린으로 구성된 그룹으로부터 선택된 하나 이상의 용매, 바람직하게는 물 및 에탄올, 바람직하게는 물을 첨가하여 약 10 ℃ 내지 100 ℃ 바람직하게는 60℃ 내지 90℃에서 약 1시간 내지 5시간 동안 열수 추출, 환류 냉각 추출, 침지 추출 또는 압력추출 등의 추출방법을 사용하여, 바람직하게는 환류 냉각 추출하는 제 1단계; 상기 추출물을 1회 내지 5회 원심분리, 감압여과, 농축 및 동결건조 하는 제 2단계를 포함하는 제조방법을 통하여 본 발명의 부평초 추출물을 수득할 수 있다.Butanol, acetone, ethyl acetate, hexane, butylene glycol, propylene glycol, propylene glycol, propylene glycol, propylene glycol, butylene glycol, , Water, and ethanol, preferably water, at a temperature of about 10 캜 to 100 캜, preferably at a temperature of 60 캜 to 90 캜 A first step of subjecting the mixture to an extraction method such as hot water extraction, reflux cooling extraction, immersion extraction or pressure extraction for about 1 to 5 hours, preferably by reflux cooling extraction; The extract of the present invention can be obtained by centrifugation, filtration under reduced pressure, and concentration and lyophilization for 1 to 5 times.

본 발명자들은 본 발명의 부평초 추출물에 대하여 DPPH 자유 라디칼 소거활성, ABTS 라디칼 양이온 소거능 저해활성, 크산틴 옥시다제(Xanthine oxidase) 저해활성 등의 항산화효과; 높은 세포 생존률; 티로시나제 (Tyrosinase) 저해활성, 세포내 티로시나제(Cellular tyrosinase) 저해활성 멜라닌(melanin) 생합성 저해 활성, 미백과 관계되어진 티로시나제(tyrosinase) 단백질 발현억제 등의 미백활성; 엘라스타제 (Elastase) 저해활성, MMP-1저해활성, 프로-콜라게나제(pro-collagenase) 저해활성 실험 등을 통한 주름개선효과 등을 확인하여 미백 및 피부노화 치료 및 예방용 조성물로 유용함을 확인하였다.The inventors of the present invention found that the extract of Buchungcho extract of the present invention has an antioxidative effect such as DPPH free radical scavenging activity, ABTS radical scavenging activity inhibiting activity, and xanthine oxidase inhibiting activity; High cell viability; Tyrosinase inhibitory activity, Cellular tyrosinase Inhibitory activity Melanin inhibitory activity, whitening activity such as inhibition of tyrosinase protein expression associated with whitening; It is useful as a composition for the treatment and prevention of whitening and skin aging by confirming the wrinkle-reducing effect through the Elastase inhibitory activity, the MMP-1 inhibitory activity and the pro-collagenase inhibitory activity experiment Respectively.

또한, 본 발명의 부평초 추출물 역시 독성 및 부작용 등의 문제가 없으며, 피부 첩포 시험에서 무자극 시료임이 입증되었으므로 장기간 사용 시에도 안심하고 사용할 수 있다.In addition, the Puccio extract of the present invention has no toxicity and side effects, and has proved to be a non-irritant sample in the skin patch test, so that it can be safely used even in long-term use.

본 발명의 부평초 추출물을 함유하는 피부외용 약학조성물은 크림, 젤, 패취, 분무제, 연고제, 경고제, 로션제, 리니멘트제, 파스타제 또는 카타플라스마제의 피부 외용제 형태의 약학조성물로 제조하여 사용할 수 있으나, 이에 한정하는 것은 아니다.The dermatological pharmaceutical composition containing the Buchungcho extract of the present invention may be manufactured and used as a pharmaceutical composition in the form of a cream, gel, patch, spray, ointment, warning agent, lotion, liniment, pasta or cataplasma But is not limited thereto.

본 발명의 부평초 추출물의 바람직한 투여량은 환자의 상태 및 체중, 질병의 정도, 약물형태, 투여경로 및 기간에 따라 다르지만, 당업자에 의해 적절하게 선택될 수 있다. 그러나 바람직한 효과를 위해서, 본 발명의 부평초 추출물은 1일 0.0001 내지 100 ㎎/㎏으로, 바람직하게는 0.001 내지 10 ㎎/㎏으로 투여하는 것이 좋다. 투여는 하루에 한번 투여할 수도 있고, 수회 나누어 투여할 수도 있다. 상기 투여량은 어떠한 면으로든 본 발명의 범위를 한정하는 것은 아니다. The preferred dosage of the Bucurrhoeae extract of the present invention varies depending on the condition and body weight of the patient, the degree of disease, the type of drug, the route of administration and the period of time, but can be appropriately selected by those skilled in the art. However, in order to obtain the desired effect, it is preferable that the Puchoncho extract of the present invention is administered at 0.0001 to 100 mg / kg per day, preferably 0.001 to 10 mg / kg per day. The administration may be carried out once a day or divided into several times. The dose is not intended to limit the scope of the invention in any way.

본 발명의 부평초 추출물은 미백 효과를 갖는 화장품 및 세안제 등에 다양하게 이용될 수 있다.The Pucci extract of the present invention can be used variously in cosmetics and cleansers having a whitening effect.

본 조성물을 첨가할 수 있는 제품으로는, 예를 들어, 화장수, 스킨, 로션, 영양로션, 영양크림, 맛사지크림, 에센스, 팩 등과 같은 화장품류와 클렌징, 세안제, 비누, 트리트먼트, 미용액 등이 있다.Examples of products to which the present composition can be added include cosmetics such as lotion, skin, lotion, nutrition lotion, nutritional cream, massage cream, essence, pack, cleansing, cleanser, soap, have.

본 발명의 화장료는 수용성 비타민, 유용성 비타민, 고분자 펩티드, 고분자 다당, 스핑고 지질 및 해초 엑기스로 이루어진 군에서 선택된 조성물을 포함한다.The cosmetic composition of the present invention comprises a composition selected from the group consisting of water-soluble vitamins, oil-soluble vitamins, high molecular weight peptides, polymeric polysaccharides, sphingolipids and seaweed extracts.

수용성 비타민으로서는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 비타민 B1, 비타민 B2, 비타민 B6, 피리독신, 염산피리독신, 비타민 B12, 판토텐산, 니코틴산, 니코틴산아미드, 엽산, 비타민 C, 비타민 H 등을 들 수 있으며, 그들의 염 (티아민염산염, 아스코르빈산나트륨염 등)이나 유도체 (아스코르빈산-2-인산나트륨염, 아스코르빈산-2-인산마그네슘염 등)도 본 발명에서 사용할 수 있는 수용성 비타민에 포함된다. 수용성 비타민은 미생물 변환법, 미생물의 배양물로부터의 정제법, 효소법 또는 화학 합성법 등의 통상의 방법에 의해 수득할 수 있다.The water-soluble vitamin is not particularly limited as long as it can be compounded in cosmetics. Preferably, vitamin B, vitamin B2, vitamin B6, pyridoxine, pyridoxine hydrochloride, vitamin B12, pantothenic acid, nicotinic acid, nicotinic acid amide, folic acid, vitamin C, And their salts (thiamine hydrochloride, sodium ascorbate, etc.) or derivatives (sodium ascorbic acid-2-phosphate, magnesium ascorbate-2-phosphate etc.) can also be added to water-soluble vitamins . The water-soluble vitamin can be obtained by a conventional method such as a microorganism conversion method, a purification method from a culture of a microorganism, an enzymatic method, or a chemical synthesis method.

유용성 비타민으로서는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 비타민 A, 카로틴, 비타민 D2, 비타민 D3, 비타민 E (d1-알파 토코페롤, d-알파 토코페롤, d-알파 토코페롤) 등을 들 수 있으며, 그들의 유도체 (팔미틴산아스코르빈, 스테아르산아스코르빈, 디팔미틴산아스코르빈, 아세트산 dl-알파 토코페롤, 니코틴산 dl-알파 토코페롤비타민 E, dl-판토테닐알코올, D-판토테닐알코올, 판토테닐에틸에테르 등) 등도 본 발명에서 사용되는 유용성 비타민에 포함된다. 유용성 비타민은 미생물 변환법, 미생물의 배양물로부터의 정제법, 효소 또는 화학 합성법 등의 통상의 방법에 의해 취득할 수 있다.Usable vitamins include vitamins such as vitamin A, carotene, vitamin D2, vitamin D3, vitamin E (d1-alpha tocopherol, d-alpha tocopherol, d-alpha tocopherol) , Derivatives thereof (such as palmitic acid ascorbin, stearic acid ascorbic acid, dipalmitic acid ascorbin, dl-alpha tocopherol acetic acid, dl-alpha tocopherol nicotinic acid vitamin E, dl-pantothenyl alcohol, D-pantothenyl alcohol, Ether, etc.) are also included in the usable vitamins used in the present invention. Usability Vitamins can be obtained by a conventional method such as a microorganism conversion method, a purification method from a culture of a microorganism, an enzyme or a chemical synthesis method.

고분자 펩티드로서는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 콜라겐, 가수 분해 콜라겐, 젤라틴, 엘라스틴, 가수 분해 엘라스틴, 케라틴 등을 들 수 있다. 고분자 펩티드는 미생물의 배양액으로부터의 정제법, 효소법 또는 화학 합성법 등의 통상의 방법에 의해 정제 취득할 수 있으며, 또는 통상 돼지나 소 등의 진피, 누에의 견섬유 등의 천연물로부터 정제하여 사용할 수 있다.The polymeric peptide may be any compound as long as it can be compounded in cosmetics, and examples thereof include collagen, hydrolyzed collagen, gelatin, elastin, hydrolyzed elastin, and keratin. The polymeric peptide can be obtained by a conventional method such as purification from a culture broth of a microorganism, an enzymatic method, or a chemical synthesis method, or it can be purified from natural products such as ducks such as pigs and cows and silk fiber of silkworms.

고분자 다당으로서는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 히드록시에틸셀룰로오스, 크산탄검, 히알루론산나트륨, 콘드로이틴 황산 또는 그 염 (나트륨염 등) 등을 들 수 있다. 예를 들어, 콘드로이틴 황산 또는 그 염 등은 통상 포유동물이나 어류로부터 정제하여 사용할 수 있다.The polymeric polysaccharide may be any compound as long as it can be incorporated in cosmetics, and examples thereof include hydroxyethyl cellulose, xanthan gum, sodium hyaluronate, chondroitin sulfate or a salt thereof (sodium salt, etc.). For example, chondroitin sulfate or a salt thereof can be usually purified from mammals or fish.

스핑고 지질로서는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 세라미드, 피토스핑고신, 스핑고당지질 등을 들 수 있다. 스핑고 지질은 통상 포유류, 어류, 패류, 효모 또는 식물 등으로부터 통상의 방법에 의해 정제하거나 화학 합성법에 의해 취득할 수 있다.Sphingo lipids may be any as long as they can be incorporated into cosmetics, and preferable examples thereof include ceramides, phytosphingosine and sphingoglycolipids. Sphingoid lipids can be purified from ordinary mammals, fish, shellfish, yeast or plants by conventional methods or can be obtained by chemical synthesis.

해초 엑기스로는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 갈조 엑기스, 홍조 엑기스, 녹조 엑기스 등을 들 수 있으며, 또, 이들의 해초 엑기스로부터 정제된 칼라기난, 아르긴산, 아르긴산나트륨, 아르긴산칼륨 등도 본 발명에서 사용되는 해초 엑기스에 포함된다. 해초 엑기스는 해초로부터 통상의 방법에 의해 정제하여 취득할 수 있다.The seaweed extract may be any of those which can be compounded in cosmetics. Preferably, the seaweed extract is selected from the group consisting of algae extract, red pepper extract, green algae extract and the like. Also, the algae extract may be colored guanine, arginic acid, Potassium alginate and the like are also included in the seaweed extract used in the present invention. Seaweed extract can be obtained from seaweed by a conventional method.

본 발명의 화장료에는 상기 필수 성분과 더불어 필요에 따라 통상 화장료에 배합되는 다른 성분을 배합해도 된다.The cosmetic of the present invention may be blended with other essential ingredients, if necessary, in combination with the essential ingredients.

이외에 첨가해도 되는 배합 성분으로서는 유지 성분, 보습제, 에몰리엔트제, 계면 활성제, 유기 및 무기 안료, 유기 분체, 자외선 흡수제, 방부제, 살균제, 산화 방지제, 식물 추출물, pH 조정제, 알콜, 색소, 향료, 혈행 촉진제, 냉감제, 제한(制汗)제, 정제수 등을 들 수 있다.Examples of the compounding ingredients that may be added include organic solvents such as a preservative component, a moisturizer, an emollient, a surfactant, an organic and inorganic pigment, an organic powder, an ultraviolet absorbent, a preservative, a bactericide, an antioxidant, a plant extract, a pH adjuster, A blood circulation accelerator, a cold agent, an antiperspirant agent, and purified water.

유지 성분으로서는 에스테르계 유지, 탄화수소계 유지, 실리콘계 유지, 불소계 유지, 동물 유지, 식물 유지 등을 들 수 있다.Examples of the oil retaining component include ester-based oil retaining, hydrocarbon-based oil retaining, silicone-based oil retaining, fluoric oil retaining, animal retention and plant retention.

에스테르계 유지로서는 트리2-에틸헥산산글리세릴, 2-에틸헥산산세틸, 미리스틴산이소프로필, 미리스틴산부틸, 팔미틴산이소프로필, 스테아르산에틸, 팔미틴산옥틸, 이소스테아르산이소세틸, 스테아르산부틸, 리놀레산에틸, 리놀레산이소프로필, 올레인산에틸, 미리스틴산이소세틸, 미리스틴산이소스테아릴, 팔미틴산이소스테아릴, 미리스틴산옥틸도데실, 이소스테아르산이소세틸, 세바신산디에틸, 아디핀산디이소프로필, 네오펜탄산이소알킬, 트리(카프릴, 카프린산)글리세릴, 트리2-에틸헥산산트리메틸롤프로판, 트리이소스테아르산트리메틸롤프로판, 테트라2-에틸헥산산펜타엘리슬리톨, 카프릴산세틸, 라우린산데실, 라우린산헥실, 미리스틴산데실, 미리스틴산미리스틸, 미리스틴산세틸, 스테아르산스테아릴, 올레인산데실, 리시노올레인산세틸, 라우린산이소스테아릴, 미리스틴산이소트리데실, 팔미틴산이소세틸, 스테아르산옥틸, 스테아르산이소세틸, 올레인산이소데실, 올레인산옥틸도데실, 리놀레산옥틸도데실, 이소스테아르산이소프로필, 2-에틸헥산산세토스테아릴, 2-에틸헥산산스테아릴, 이소스테아르산헥실, 디옥탄산에틸렌글리콜, 디올레인산에틸렌글리콜, 디카프린산프로필렌글리콜, 디(카프릴,카프린산)프로필렌글리콜, 디카프릴산프로필렌글리콜, 디카프린산네오펜틸글리콜, 디옥탄산네오펜틸글리콜, 트리카프릴산글리세릴, 트리운데실산글리세릴, 트리이소팔미틴산글리세릴, 트리이소스테아르산글리세릴, 네오펜탄산옥틸도데실, 옥탄산이소스테아릴, 이소노난산옥틸, 네오데칸산헥실데실, 네오데칸산옥틸도데실, 이소스테아르산이소세틸, 이소스테아르산이소스테아릴, 이소스테아르산옥틸데실, 폴리글리세린올레인산에스테르, 폴리글리세린이소스테아르산에스테르, 시트르산트리이소세틸, 시트르산트리이소알킬, 시트르산트리이소옥틸, 락트산라우릴, 락트산미리스틸, 락트산세틸, 락트산옥틸데실, 시트르산트리에틸, 시트르산아세틸트리에틸, 시트르산아세틸트리부틸, 시트르산트리옥틸, 말산디이소스테아릴, 히드록시스테아르산 2-에틸헥실, 숙신산디2-에틸헥실, 아디핀산디이소부틸, 세바신산디이소프로필, 세바신산디옥틸, 스테아르산콜레스테릴, 이소스테아르산콜레스테릴, 히드록시스테아르산콜레스테릴, 올레인산콜레스테릴, 올레인산디히드로콜레스테릴, 이소스테아르산피트스테릴, 올레인산피트스테릴, 12-스테알로일히드록시스테아르산이소세틸, 12-스테알로일히드록시스테아르산스테아릴, 12-스테알로일히드록시스테아르산이소스테아릴 등의 에스테르계 등을 들 수 있다.Examples of ester-based fats include glyceryl tri-2-ethylhexanoate, cetyl 2-ethylhexanoate, isopropyl myristate, butyl myristate, isopropyl palmitate, ethyl stearate, octyl palmitate, isostearyl isostearate, Butyl isopropyl myristate, isopropyl myristate, isopropyl myristate, isopropyl myristate, isopropyl myristate, isopropyl myristate, butyl, ethyl linoleate, isopropyl linoleate, ethyl oleate, isosilyl myristate, isostearic acid isostearyl, isostearyl palmitate, octyldodecyl myristate, Trimethylol propane, triisostearic acid trimethylol propane, tetra 2-ethylhexanoic acid pentaerythritol tetra (2-ethylhexanoate) , Decyl caprylate, decyl laurate, hexyl laurate, myristate decyl, myristyl myristate, myristine monoethyl stearate, stearyl stearate, decyl oleate, ricinoleic acid tri , Isostearyl stearate, isostearyl stearate, isodecyl stearate, octyldodecyl oleate, octyldodecyl linoleate, isopropyl isostearate, isopropyl stearate, isopropyl stearate, isopropyl stearate, -Hexyl stearate, stearyl ethylhexanoate, stearyl 2-ethylhexanoate, hexyl isostearate, ethylene glycol dioctanoate, ethylene glycol dioleate, propylene glycol dicaprate, di (capryl, capric acid) propylene glycol, Propyleneglycol propionate, propyleneglycol propionate, dicaproic acid neopentyl glycol, dioctanoic acid neopentyl glycol, tricarboxylic acid glyceryl, triunsaturated glyceryl, triisopalmitic acid glyceryl, triisostearic acid glyceryl, neopentanoic acid octyldodecyl Octanoic acid octanoate, octanoic acid octanoate, octanoic acid octanoate, octanoic acid octanoate, octanoic acid octanoate, octanoic acid octanoate, Octyldecyl lactate, octyldecyl lactate, octyldecyl lactate, polyglycerin oleic acid ester, polyglycerin isostearic acid ester, triisocetyl citrate, triisobutyl citrate, triisooctyl citrate, lauryl lactate, myristyl lactate, But are not limited to, ethyl, acetyltriethyl citrate, acetyltributyl citrate, trioctyl citrate, diisostearyl malate, 2-ethylhexyl hydroxystearate, di-2-ethylhexyl succinate, diisobutyl adipate, diisopropyl sebacate, But are not limited to, dioctyl sebacate, stearic acid cholesteryl, isostearic acid cholesteryl, hydroxystearic acid cholesteryl, oleic acid cholesteryl, oleic acid dihydrocholesteryl, isostearic acid pitostearyl, Stearoyl hydroxystearic acid isostearyl, 12-stearoyl stearyl hydroxystearate, 12-stearo And monohydroxystearic acid and esters such as sostearyl.

탄화 수소계 유지로서는 스쿠알렌, 유동 파라핀, 알파-올레핀올리고머, 이소파라핀, 세레신, 파라핀, 유동 이소파라핀, 폴리부덴, 마이크로크리스탈린왁스, 와셀린 등의 탄화 수소계 유지 등을 들 수 있다.Examples of the hydrocarbon hydrocarbon-based fats include hydrocarbon fats and oils such as squalene, liquid paraffin, alpha-olefin oligomer, isoparaffin, ceresin, paraffin, floating isoparaffin, polybutene, microcrystalline wax and vaseline.

실리콘계 유지로서는 폴리메틸실리콘, 메틸페닐실리콘, 메틸시클로폴리실록산, 옥타메틸폴리실록산, 데카메틸폴리실록산, 도데카메틸시클로실록산, 디메틸실록산ㆍ메틸세틸옥시실록산 공중합체, 디메틸실록산ㆍ메틸스테알록시실록산 공중합체, 알킬 변성 실리콘유, 아미노 변성 실리콘유 등을 들 수 있다.Examples of silicone based oils include polymethyl silicone, methylphenyl silicone, methyl cyclopolysiloxane, octamethylpolysiloxane, decamethylpolysiloxane, dodecamethylcyclosiloxane, dimethylsiloxane-methylcetyloxysiloxane copolymer, dimethylsiloxane-methylstarchoxysiloxane copolymer, alkyl Modified silicone oils, and amino-modified silicone oils.

불소계 유지로서는 퍼플루오로폴리에테르 등을 들 수 있다.Examples of the fluorine-based oil include perfluoropolyether and the like.

동물 또는 식물 유지로서는 아보카도유, 아르몬드유, 올리브유, 참깨유, 쌀겨유, 새플라워유, 대두유, 옥수수유, 유채유, 행인(杏仁)유, 팜핵유, 팜유, 피마자유, 해바라기유, 포도종자유, 면실유, 야자유, 쿠쿠이너트유, 소맥배아유, 쌀 배아유, 시아버터, 월견초유, 마커데이미아너트유, 메도홈유, 난황유, 우지(牛脂), 마유, 밍크유, 오렌지라피유, 호호바유, 캔데리러왁스, 카르나바왁스, 액상 라놀린, 경화피마자유 등의 동물 또는 식물 유지를 들 수 있다.Examples of animal or vegetable oils include avocado oil, almond oil, olive oil, sesame oil, rice bran oil, new flower oil, soybean oil, corn oil, rape oil, apricot kernel oil, palm kernel oil, palm oil, castor oil, , Corn oil, palm oil, palm oil, cucumber nut oil, wheat germ oil, rice germ oil, shea butter, coltsfoot colostrum, marker daisy nut oil, mead home oil, egg oil, , Canned wax, carnauba wax, liquid lanolin, hardened castor oil, and the like.

보습제로서는 수용성 저분자 보습제, 지용성 분자 보습제, 수용성 고분자, 지용성 고분자 등을 들 수 있다.Examples of the moisturizing agent include water-soluble low-molecular moisturizing agents, oil-soluble molecular moisturizing agents, water-soluble polymers, and oil-soluble polymers.

수용성 저분자 보습제로서는 세린, 글루타민, 솔비톨, 만니톨, 피롤리돈-카르복실산나트륨, 글리세린, 프로필렌글리콜, 1,3-부틸렌글리콜, 에틸렌글리콜, 폴리에틸렌글리콜B(중합도 n = 2 이상), 폴리프로필렌글리콜(중합도 n = 2 이상), 폴리글리세린B(중합도 n = 2 이상), 락트산, 락트산염 등을 들 수 있다.Examples of the water-soluble low-molecular moisturizing agent include serine, glutamine, sorbitol, mannitol, sodium pyrrolidone-carboxylate, glycerin, propylene glycol, 1,3-butylene glycol, ethylene glycol, polyethylene glycol B Glycol (polymerization degree n = 2 or more), polyglycerin B (polymerization degree n = 2 or more), lactic acid, lactic acid salt and the like.

지용성 저분자 보습제로서는 콜레스테롤, 콜레스테롤에스테르 등을 들 수 있다.Examples of the lipid-soluble low-molecular moisturizing agent include cholesterol and cholesterol ester.

수용성 고분자로서는 카르복시비닐폴리머, 폴리아스파라긴산염, 트라가칸트, 크산탄검, 메틸셀룰로오스, 히드록시메틸셀룰로오스, 히드록시에틸셀룰로오스, 히드록시프로필셀룰로오스, 카르복시메틸셀룰로오스, 수용성 키틴, 키토산, 덱스트린 등을 들 수 있다.Examples of the water-soluble polymer include carboxyvinyl polymer, polyaspartic acid, tragacanth, xanthan gum, methylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, carboxymethylcellulose, water-soluble chitin, chitosan, dextrin, etc. .

지용성 고분자로서는 폴리비닐피롤리돈ㆍ에이코센 공중합체, 폴리비닐피롤리돈ㆍ헥사데센 공중합체, 니트로셀룰로오스, 덱스트린지방산에스테르, 고분자 실리콘 등을 들 수 있다.Examples of the oil-soluble polymer include polyvinylpyrrolidone / eicosene copolymer, polyvinylpyrrolidone / hexadecene copolymer, nitrocellulose, dextrin fatty acid ester, and polymer silicone.

에몰리엔트제로서는 장쇄아실글루타민산콜레스테릴에스테르, 히드록시스테아르산콜레스테릴, 12-히드록시스테아르산, 스테아르산, 로진산, 라놀린지방산콜레스테릴에스테르 등을 들 수 있다.Examples of the emollients include long chain acyl glutamic acid cholesteryl ester, hydroxystearic acid cholesteryl, 12-hydroxystearic acid, stearic acid, rosin acid and lanolin fatty acid cholesteryl ester.

계면 활성제로서는 비이온성 계면 활성제, 음이온성 계면 활성제, 양이온성 계면 활성제, 양성 계면 활성제 등을 들 수 있다.Examples of the surfactant include nonionic surfactants, anionic surfactants, cationic surfactants, and amphoteric surfactants.

비이온성 계면 활성제로서는 자기 유화형 모노스테아르산글리세린, 프로필렌글리콜지방산에스테르, 글리세린지방산에스테르, 폴리글리세린지방산에스테르, 솔비탄지방산에스테르, POE (폴리옥시에틸렌)솔비탄지방산에스테르, POE 솔비트지방산에스테르, POE 글리세린지방산에스테르, POE 알킬에테르, POE 지방산에스테르, POE 경화피마자유, POE 피마자유, POEㆍPOP (폴리옥시에틸렌ㆍ폴리옥시프로필렌) 공중합체, POEㆍPOP 알킬에테르, 폴리에테르변성실리콘, 라우린산알카놀아미드, 알킬아민옥시드, 수소첨가대두인지질 등을 들 수 있다.Examples of the nonionic surfactant include self emulsifying monostearate glycerin, propylene glycol fatty acid ester, glycerin fatty acid ester, polyglycerin fatty acid ester, sorbitan fatty acid ester, POE (polyoxyethylene) sorbitan fatty acid ester, POE sorbit fatty acid ester, POE (Polyoxyethylene / polyoxypropylene) copolymer, POE.POP alkyl ether, polyether-modified silicone, polyether-modified silicone, polyoxyethylene-polyoxypropylene (POE) Alkanolamides, alkylamine oxides, hydrogenated soybean phospholipids, and the like.

음이온성 계면 활성제로서는 지방산비누, 알파-아실술폰산염, 알킬술폰산염, 알킬알릴술폰산염, 알킬나프탈렌술폰산염, 알킬황산염, POE 알킬에테르황산염, 알킬아미드황산염, 알킬인산염, POE 알킬인삼염, 알킬아미드인산염, 알킬로일알킬타우린염, N-아실아미노산염, POE 알킬에테르카르복실산염, 알킬술포숙신산염, 알킬술포아세트산나트륨, 아실화 가수분해 콜라겐펩티드염, 퍼플루오로알킬인산에스테르 등을 들 수 있다.Examples of the anionic surfactant include fatty acid soap, alpha-acylsulfonate, alkylsulfonate, alkylarylsulfonate, alkylnaphthalenesulfonate, alkylsulfate, POE alkyl ether sulfate, alkylamide sulfate, alkyl phosphate, POE alkyl ginseng salt, Alkylsulfosuccinic acid salts, acylated hydrolyzed collagen peptide salts, and perfluoroalkyl phosphoric acid esters, and the like can be mentioned. have.

양이온성 계면 활성제로서는 염화알킬트리메틸암모늄, 염화스테아릴트리메틸암모늄, 브롬화스테아릴트리메틸암모늄, 염화세토스테아릴트리메틸암모늄, 염화디스테아릴디메틸암모늄, 염화스테아릴디메틸벤질암모늄, 브롬화베헤닐트리메틸암모늄, 염화벤잘코늄, 스테아르산디에틸아미노에틸아미드, 스테아르산디메틸아미노프로필아미드, 라놀린 유도체 제 4급 암모늄염 등을 들 수 있다.Examples of the cationic surfactant include alkyl trimethyl ammonium chloride, stearyl trimethyl ammonium chloride, stearyl trimethyl ammonium bromide, cetostearyl trimethyl ammonium chloride, distearyl dimethyl ammonium chloride, stearyl dimethyl benzyl ammonium chloride, behenyl trimethyl ammonium chloride, Benzalkonium, diethylaminoethylamide stearate, dimethylaminopropylamide stearate, quaternary ammonium salts of lanolin derivatives, and the like.

양성 계면 활성제로서는 카르복시베타인형, 아미드베타인형, 술포베타인형, 히드록시술포베타인형, 아미드술포베타인형, 포스포베타인형, 아미노카르복실산염형, 이미다졸린 유도체형, 아미드아민형 등의 양성 계면 활성제 등을 들 수 있다.Examples of the amphoteric surfactant include carboxybetaine type, amide betaine type, sulfobetaine type, hydroxysulfobetaine type, amidosulfobetaine type, phosphobetaine type, aminocarboxylate type, imidazoline derivative type and amide amine type Amphoteric surfactants and the like.

유기 및 무기 안료로서는 규산, 무수규산, 규산마그네슘, 탤크, 세리사이트, 마이카, 카올린, 벵갈라, 클레이, 벤토나이트, 티탄피막운모, 옥시염화비스무트, 산화지르코늄, 산화마그네슘, 산화아연, 산화티탄, 산화알루미늄, 황산칼슘, 황산바륨, 황산마그네슘, 탄산칼슘, 탄산마그네슘, 산화철, 군청, 산화크롬, 수산화크롬, 칼라민 및 이들의 복합체등의 무기 안료 ; 폴리아미드, 폴리에스테르, 폴리프로필렌, 폴리스티렌, 폴리우레탄, 비닐수지, 요소수지, 페놀수지, 불소수지, 규소수지, 아크릴수지, 멜라민수지, 에폭시수지, 폴리카보네이트수지, 디비닐벤젠ㆍ스티렌 공중합체, 실크파우더, 셀룰로오스, CI 피그먼트옐로우, CI 피그먼트오렌지 등의 유기 안료 및 이들의 무기 안료와 유기 안료의 복합 안료 등을 들 수 있다.Examples of the organic and inorganic pigments include inorganic pigments such as silicic acid, silicic anhydride, magnesium silicate, talc, sericite, mica, kaolin, Bengala, clay, bentonite, titanium mica, titanium oxide, bismuth chloride, zirconium oxide, magnesium oxide, Inorganic pigments such as calcium sulfate, barium sulfate, magnesium sulfate, calcium carbonate, magnesium carbonate, iron oxide, chromium oxide, chromium oxide, chromium hydroxide, But are not limited to, polyamide, polyester, polypropylene, polystyrene, polyurethane, vinyl resin, urea resin, phenol resin, fluororesin, silicon resin, acrylic resin, melamine resin, epoxy resin, polycarbonate resin, Silk powder, cellulose, CI Pigment Yellow, CI Pigment Orange, and composite pigments of inorganic pigments and organic pigments thereof.

유기 분체로서는 스테아르산칼슘 등의 금속비누 ; 세틸린산아연나트륨, 라우릴린산아연, 라우릴린산칼슘 등의 알킬인산금속염 ; N-라우로일-베타-알라닌칼슘, N-라우로일-베타-알라닌아연, N-라우로일글리신칼슘 등의 아실아미노산 다가금속염 ; N-라우로일-타우린칼슘, N-팔미토일-타우린칼슘 등의 아미드술폰산 다가금속염 ; N-엡실론-라우로일-L-리진, N-엡실론-팔미토일리진, N-알파-파리토일올니틴, N-알파-라우로일아르기닌, N-알파-경화우지지방산아실아르기닌 등의 N-아실염기성아미노산 ; N-라우로일글리실글리신 등의 N-아실폴리펩티드 ; 알파-아미노카프릴산, 알파-아미노라우린산 등의 알파-아미노지방산 ; 폴리에틸렌, 폴리프로필렌, 나일론, 폴리메틸메타크릴레이트, 폴리스티렌, 디비닐벤젠ㆍ스티렌 공중합체, 사불화에틸렌 등을 들 수 있다.As the organic powder, metallic soap such as calcium stearate; Metal salts of alkyl phosphates such as sodium zinc cetylate, zinc laurylate and calcium lauryl laurate; Acylamino acid polyvalent metal salts such as N-lauroyl-beta-alanine calcium, N-lauroyl-beta-alanine zinc and N-lauroylglycine calcium; Amidosulfonic acid multivalent metal salts such as N-lauroyl-taurine calcium and N-palmitoyl-taurine calcium; Such as N-epsilon-lauroyl-L-lysine, N-epsilon-palmitoylidene, N-alpha-paratyylnitine, N-alpha-lauroyl arginine, Acyl basic amino acids; N-acylpolypeptides such as N-lauroylglycylglycine; Alpha-amino fatty acids such as alpha-aminocaprylic acid, alpha-aminoaurauric acid, and the like; Polyethylene, polypropylene, nylon, polymethylmethacrylate, polystyrene, divinylbenzene-styrene copolymer, ethylene tetrafluoride, and the like.

자외선 흡수제로서는 파라아미노벤조산, 파라아미노벤조산에틸, 파라아미노벤조산아밀, 파라아미노벤조산옥틸, 살리실산에틸렌글리콜, 살리신산페닐, 살리신산옥틸, 살리신산벤질, 살리신산부틸페닐, 살리신산호모멘틸, 계피산벤질, 파라메톡시계피산-2-에톡시에틸, 파라메톡시계피산옥틸, 디파라메톡시계피산모노-2-에틸헥산글리세릴, 파라메톡시계피산이소프로필, 디이소프로필ㆍ디이소프로필계피산에스테르 혼합물, 우로카닌산, 우로카닌산에틸, 히드록시메톡시벤조페논, 히드록시메톡시벤조페논술폰산 및 그 염, 디히드록시메톡시벤조페논, 디히드록시메톡시벤조페논디술폰산나트륨, 디히드록시벤조페논, 테트라히드록시벤조페논, 4-tert-부틸-4'-메톡시디벤조일메탄, 2,4,6-트리아닐리노-p-(카르보-2'-에틸헥실-1'-옥시)-1,3,5-트리아진, 2-(2-히드록시-5-메틸페닐)벤조트리아졸 등을 들 수 있다.Examples of ultraviolet absorbers include paraaminobenzoic acid, ethyl parnamobenzoate, amyl paranobenzoate, octyl paranobenzoate, ethyleneglycol salicylate, phenyl salicylate, benzyl salicylate, benzyl salicylate, butylphenyl salicylate, homomenthyl salicylate, benzyl cinnamate , Octyl methoxycinnamate, dioctyl methoxycinnamate, mono-2-ethylhexane glyceryl dipyrromethoxycinnamate, isopropyl paratumoxycinnamate, diisopropyl-diisopropyl cinnamate ester mixture, Carninoic acid, ethyl urocanoate, hydroxymethoxybenzophenone, hydroxymethoxybenzophenone sulfonic acid and salts thereof, dihydroxymethoxybenzophenone, sodium dihydroxymethoxybenzophenone disulfonate, dihydroxybenzophenone , Tetrahydroxybenzophenone, 4- tert -butyl-4'-methoxydibenzoylmethane, 2,4,6-trianylino- p- (carbo-2'-ethylhexyl-1'- , 3,5-triazine, 2- (2- And the like can be mentioned hydroxy-5-methylphenyl) benzotriazole.

살균제로서는 히노키티올, 트리클로산, 트리클로로히드록시디페닐에테르, 크로르헥시딘글루콘산염, 페녹시에탄올, 레조르신, 이소프로필메틸페놀, 아줄렌, 살리칠산, 진크필리티온, 염화벤잘코늄, 감광소 301 호, 모노니트로과이어콜나트륨, 운데시렌산 등을 들 수 있다.Examples of the disinfectant include hinokitiol, trichloroacid, trichlorohydroxydiphenyl ether, crohexidine gluconate, phenoxyethanol, resorcin, isopropylmethylphenol, azulene, salicylic acid, zinc filitione, benzalkonium chloride, No. 301, mononitro and eicol sodium, and undecylenic acid.

산화 방지제로서는 부틸히드록시아니솔, 갈릭산프로필, 엘리소르빈산 등을 들 수 있다.Examples of the antioxidant include butylhydroxyanisole, gallic acid propyl, and eicosorbic acid.

pH 조정제로서는 시트르산, 시트르산나트륨, 말산, 말산나트륨, 프말산, 프말산나트륨, 숙신산, 숙신산나트륨, 수산화나트륨, 인산일수소나트륨 등을 들 수 있다.Examples of the pH adjuster include citric acid, sodium citrate, malic acid, sodium malate, fumaric acid, sodium fumarate, succinic acid, sodium succinate, sodium hydroxide, sodium monohydrogenphosphate and the like.

알코올로서는 세틸알코올 등의 고급 알코올을 들 수 있다.Examples of the alcohol include higher alcohols such as cetyl alcohol.

또한, 이외에 첨가해도 되는 배합 성분은 이에 한정되는 것은 아니며, 또, 상기 어느 성분도 본 발명의 목적 및 효과를 손상시키지 않는 범위 내에서 배합 가능하지만, 총중량에 대하여 바람직하게는 0.01 - 5 % 중량, 보다 바람직하게는 0.01 - 3 % 중량로 배합된다.In addition, any of the above components may be blended within the range not to impair the objects and effects of the present invention, but it is preferably 0.01 to 5% by weight based on the total weight, Preferably 0.01 to 3% by weight.

본 발명의 화장료는 용액, 유화물, 점성형 혼합물 등의 형상을 취할 수 있다.The cosmetic of the present invention may take the form of a solution, an emulsion, a viscous mixture or the like.

본 발명의 화장료 조성물에 포함되는 성분은 유효성분으로서 상기 부평초 추출물 이외에 화장료 조성물에 통상적으로 이용되는 성분들을 포함할 수 있으며, 예를 들면, 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제 및 담체를 포함한다.The ingredients contained in the cosmetic composition of the present invention may contain, as an active ingredient, the components commonly used in cosmetic compositions in addition to the above-mentioned Puchonchia extract, and may contain conventional ingredients such as stabilizers, solubilizers, vitamins, Adjuvants and carriers.

본 발명의 화장료 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어 유액, 크림, 화장수, 팩, 파운데이션, 로션, 미용액, 모발화장료 등을 들 수 있다.The cosmetic composition of the present invention can be prepared into any formulation conventionally produced in the art, and examples thereof include emulsions, creams, lotions, packs, foundations, lotions, essences, and hair cosmetics.

구체적으로, 본 발명의 화장료 조성물은 스킨로션, 스킨소프너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스쳐 로션, 영양로션, 맛사지크림, 영양크림, 모이스처크림, 핸드크림, 파운데이션, 에센스, 영양에센스, 팩, 비누, 클렌징폼, 클렌징로션, 클렌징크림, 바디로션 및 바디클린저의 제형을 포함한다.Specifically, the cosmetic composition of the present invention can be used as a skin lotion, a skin softener, a skin toner, an astringent, a lotion, a milk lotion, a moisturizing lotion, a nutrition lotion, a massage cream, a nutrition cream, a moisturizing cream, a hand cream, Packs, soaps, cleansing foams, cleansing lotions, cleansing creams, body lotions and body cleansers.

본 발명의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물섬유, 식물섬유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the present invention is a paste, cream or gel, animal fiber, plant fiber, wax, paraffin, starch, tracant, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide may be used as the carrier component .

본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component. In the case of a spray, in particular, / Propane or dimethyl ether.

본 발명의 제형이 용액 또는 유탁액의 경우에는 담체 성분으로서 용매, 용매화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌 글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.In the case of the solution or emulsion of the present invention, a solvent, a solvent or an emulsifier is used as a carrier component, and examples thereof include water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, , 3-butyl glycol oil, glycerol aliphatic ester, polyethylene glycol or sorbitan fatty acid esters.

본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.When the formulation of the present invention is a suspension, a carrier such as water, a liquid diluent such as ethanol or propylene glycol, a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, Cellulose, aluminum metahydroxide, bentonite, agar or tracant, etc. may be used.

본 발명의 제형이 계면-활성제 함유 클린징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 리놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.
When the formulation of the present invention is an interfacial active agent-containing cleansing, the carrier component may include aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyltaurate, sarcosinate, fatty acid amide Ether sulfates, alkylamidobetaines, aliphatic alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, linolenic derivatives or ethoxylated glycerol fatty acid esters.

본 발명의 부평초 추출물은 DPPH 자유 라디칼 소거활성, ABTS 라디칼 양이온 소거능 저해활성, 크산틴 옥시다제(Xanthine oxidase) 저해활성 등의 항산화효과; 높은 세포 생존률; 티로시나제 (Tyrosinase) 저해활성, 세포내 티로시나제(Cellular tyrosinase) 저해활성 멜라닌(melanin) 생합성 저해 활성, 미백과 관계되어진 티로시나제(tyrosinase) 단백질 발현억제 등의 미백활성; 엘라스타제 (Elastase) 저해활성, MMP-1저해활성, 프로-콜라게나제(pro-collagenase) 저해활성 실험 등을 통한 주름개선효과 등을 확인하여 미백 및 피부노화 치료 및 예방용 조성물로 유용하게 이용될 수 있다.
The suppuryecho extract of the present invention has an antioxidative effect such as DPPH free radical scavenging activity, ABTS radical cation scavenging activity inhibiting activity, xanthine oxidase inhibiting activity; High cell viability; Tyrosinase inhibitory activity, Cellular tyrosinase Inhibitory activity Melanin inhibitory activity, whitening activity such as inhibition of tyrosinase protein expression associated with whitening; It is useful as a composition for the treatment and prevention of whitening and skin aging by confirming the wrinkle-reducing effect through experiments such as Elastase inhibitory activity, MMP-1 inhibitory activity and pro-collagenase inhibitory activity Can be used.

도 1은 시료의 DPPH 라디칼 소거활성을 나타낸 도이고;
도 2는 시료의 ABTS 양이온 라디칼 소거활성을 나타낸 도이고;
도 3은 시료의 섬유아세포의 생존률을 나타낸 도이며;
도 4는 시료의 흑색종세포의 생존률을 나타낸 도이며;
도 5는 시료의 엘라스타제 저해활성을 나타낸 도이며;
도 6는 시료의 콜라게나제 저해활성을 나타낸 도이며;
도 7는 시료의 프로-콜라겐 저해활성을 나타낸 도이며;
도 8는 시료의 MMP-1 저해활성을 나타낸 도이며;
도 9는 시료의 티로시나제 저해활성을 나타낸 도이며;
도 10는 시료의 멜라닌 생합성에 미치는 영향을 나타낸 도이며;
도 11는 시료의 멜라노마 세포의 세포내 티로시나제 저해활성을 나타낸 도이다.
1 is a graph showing the DPPH radical scavenging activity of a sample;
2 is a graph showing the ABTS cation radical scavenging activity of a sample;
3 is a graph showing the survival rate of the fibroblasts of the sample;
4 is a graph showing the survival rate of melanoma cells of a sample;
5 is a graph showing the elastase inhibitory activity of the sample;
6 is a graph showing collagenase inhibitory activity of a sample;
7 is a graph showing the pro-collagen inhibitory activity of the sample;
8 is a graph showing the MMP-1 inhibitory activity of the sample;
9 is a graph showing the tyrosinase inhibitory activity of the sample;
10 is a graph showing the influence of the sample on melanin biosynthesis;
11 is a graph showing the intracellular tyrosinase inhibitory activity of Melanoma cells of a sample.

이하, 본 발명을 하기의 실시예 및 실험예에 의해 상세히 설명한다.Below, The present invention will be described in detail by the following examples and experimental examples.

단, 하기 실시예 및 실험예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예 및 실험예에 의해 한정되는 것은 아니다.
However, the following examples and experimental examples are illustrative of the present invention, and the content of the present invention is not limited by the following examples and experimental examples.

실시예 1. 부평초 추출물의 제조Example 1. Preparation of Puchipcheon extract

1-1. 부평초 물 추출물1-1. Puchipcheon water extract

부평초는 (주) 휴먼허브에서 구입하여 사용하였다. 열수 추출물의 경우 시료 100 g에 증류수 10배 양을 가하여 85℃에서 9시간 환류냉각 추출하여 상등액과 침전물을 분리하여 3회 반복 추출하고, 각 추출물은 12,000rpm으로 10분간 원심분리한 후 Whatman No. 1 여과지로 여과하였으며 각 추출물은 농축하여 동결건조하여 물 추출물 13.9 g 을 수득하였다(이하 SW라 함).
Bupyeongcho was purchased from Human Hub Co., Ltd. In the case of the hot-water extract, 100 g of the sample was added with 10-fold amount of distilled water, and the mixture was refluxed for cooling at 85 ° C for 9 hours to separate the supernatant and precipitate. The extract was centrifuged at 12,000 rpm for 10 minutes. 1 filter paper. Each extract was concentrated and lyophilized to obtain 13.9 g of a water extract (hereinafter referred to as SW).

1-2. 부평초 에탄올 추출물1-2. Puchoncho Ethanol Extract

부평초는 (주) 휴먼허브에서 구입하여 사용하였다. 시료 100 g에 70% 에탄올을 10배 양을 가하여 85℃에서 12시간 환류냉각 추출하여 상등액과 침전물을 분리하여 3회 반복 추출하고, 각 추출물은 12,000rpm으로 10분간 원심분리한 후 Whatman No. 1 여과지로 여과하였으며 각 추출물은 농축하여 동결건조하여 70% 에탄올 추출물 12 g을 각각 수득하였다(이하 SE라 함).
Bupyeongcho was purchased from Human Hub Co., Ltd. The supernatant and precipitate were separated by centrifugation at 85 ° C for 12 hours. The extracts were centrifuged at 12,000 rpm for 10 minutes. 1 filter paper. Each extract was concentrated and lyophilized to obtain 12 g of 70% ethanol extract (hereinafter referred to as SE).

실시예 2. 부평초 분획 추출물의 제조Example 2. Preparation of Pu-Pyungcho fraction extract

용매별 분획은 상기 실시예 1의 부평초 에탄올 추출물과 헥산을 1:1 비율(v/v)로 분획하였고, 감압 농축하여 헥산 분획물을 얻었다. 동일한 과정을 통해 에틸아세테이트 층, 부탄올 층 및 물 층을 순차적으로 가하여 각 분획물을 얻었다. 각 추출물과 용매 분획물은 농축 후 동결건조시켜 헥산 분획물 94.05 g (이하, SE-H라 함), 에틸아세테이트 분획물 68.80 g (이하, SE-E라 함), 부탄올 분획물 50.26 g (이하, SE-B라 함), 및 물 분획물 205.5 g (이하, SE-W라 함),을 각각 분말 상태로 냉장실에 보관하면서 본 실험의 시료에 사용하였다.
The supernatant fraction of the supernatant was fractionated by 1: 1 (v / v) and concentrated under reduced pressure to obtain hexane fractions. Ethyl acetate layer, butanol layer and water layer were sequentially added through the same procedure to obtain respective fractions. Each of the extracts and the solvent fractions were concentrated and lyophilized to give 94.05 g (hereinafter referred to as SE-H) of hexane fraction, 68.80 g (hereinafter referred to as SE-E) of the ethyl acetate fraction and 50.26 g , And 205.5 g of water fraction (hereinafter referred to as SE-W) were used as samples in this experiment while being stored in a refrigerated room in powder form.

실험예 1. 항산화 효과 확인Experimental Example 1. Identification

1-1. 전자 1-1. Electronic 공여능Donor ( ( electronelectron donatingdonating abilityability ) 측정) Measure

상기 실시예 시료의 전자공여능을 확인하기 위하여 문헌에 기재된 Blois의 방법을 변형하여 하기와 같이 실험을 수행하였다. (Blois MS. (1958) Antioxidant determination by the use of a stable free radical. 26, 1199-1120)In order to confirm the electron donating ability of the sample of the above example, the Blois method described in the literature was modified and the following experiment was conducted. (Blois MS. (1958) Antioxidant determination by the use of a stable free radical. 26, 1199-1120)

각 시료용액 2mL에 0.2mM의 1,1-diphenyl-2-picrylhydrazyl (DPPH) 1ml 넣고 교반한 후 30분간 방치한 다음 517nm에서 흡광도를 측정하였다. 전자공여능은 시료용액의 첨가군과 무첨가군의 흡광도 감소율로 나타내었다. DPPH radical 소거활성은 하기 수학식 1에 따라, 시료를 첨가하지 않은 대조구의 흡광도를 1/2로 환원시키는데 필요한 시료의 농도 값으로 나타내었다.1 ml of 0.2 mM 1,1-diphenyl-2-picrylhydrazyl (DPPH) was added to 2 ml of each sample solution. After stirring for 30 minutes, absorbance was measured at 517 nm. The electron donating ability was expressed by the absorbance reduction rate of the sample solution addition group and the no addition group. The DPPH radical scavenging activity was expressed by the concentration value of the sample required to reduce the absorbance of the control without addition of the sample to ½ according to the following equation (1).

Figure 112013042140537-pat00001
Figure 112013042140537-pat00001

본 실험결과, 부평초 에탄올, 열수 추출물과 에탄올 추출물의 용매별 분획물에 대한 DPPH radical 소거활성 결과는 도 1과 같이 나타내었다. 부평초 에탄올 추출물100 μg/ml 농도에서 36.1%의 소거능을 나타내었고, 열수 추출물 100 μg/ml 농도에서 24.7%의 소거능을 나타내어 에탄올 추출물이 열수 추출물보다 DPPH radical 소거활성이 우수하였다. 부평초 에탄올 추출물의 용매별 분획물의 경우 100 μg/ml 농도에서 EtOAC 분획층과 BuOH 분획층에서 각각 44.2%, 42.6%의 소거능을 나타내었다.
As a result, DPPH radical scavenging activity of Buchungcho ethanol, hot water extract and ethanol extract fraction was shown in FIG. The supernatant of ethanol extracts showed better scavenging activity than that of the hot - water extracts, indicating that the ethanol extract showed a scavenging activity of 36.1% at 100 μg / ml concentration and a 24.7% scavenging activity at the concentration of 100 μg / ml of hot - water extract. The solvent fraction of Buchung-checho ethanol extract showed 44.2% and 42.6% cleavage in the EtOAC fraction and BuOH fraction at 100 μg / ml, respectively.

1-2. 1-2. ABTSABTS 라디칼Radical 양이온  Cation 소거능Scatters 저해활성 측정 Measurement of inhibitory activity

상기 실시예 시료의 ABTS 라디칼 양이온 탈색화(radical cation decolorization) 법에 의한 항산화 효능을 시험하기 위하여 문헌에 개시된 방법을 응용하여 하기와 같이 실험하였다(Roterta, R., P. Nicoletta, P. Anna, P. Ananth, Y. Min and R.E. Catherine. 1999. Antioxidant Activity Applying an Improved ABTS Radical Cation Decolorization Assay. Radic . Biol . Med . 26, 1231-1237.)In order to test the antioxidant activity of the sample of the present invention by the radical cation decolorization (ABTS) radical cation decolorization method, the following method was applied as described below (Roterta, R., P. Nicoletta, P. Anna, P. Ananth, Y. Min and RE Catherine . 1999. Antioxidant Activity Applying an Improved ABTS Radical Cation Decolorization Assay. Radic. Biol. Med. 26, 1231-1237.)

7mM 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS, Wako Chemical Co., Japan)와 2.45mM potassium persulfate를 최종농도로 혼합하여 실온인 암소에서 24시간 동안 방치하여 ABTS+을 형성시킨 후 phosphate buffer saline (PBS, pH7.4) 로 희석하였다. 희석된 용액 100μl에 시료 50μl를 가하여 5분 동안 방치한 후 흡광도를 측정하였다. ABTS radical 소거활성은 하기 수학식 2와 같이 시료를 첨가하지 않은 대조구의 흡광도를 1/2로 환원시키는데 필요한 시료의 농도 값으로 나타내었다. 2.45 mM potassium persulfate was mixed with 7 mM 2,2'-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) (ABTS, Wako Chemical Co., Japan) and allowed to stand at room temperature for 24 hours. + , And diluted with phosphate buffered saline (PBS, pH 7.4). 50 μl of the sample was added to 100 μl of the diluted solution, and the solution was allowed to stand for 5 minutes, and the absorbance was measured. The ABTS radical scavenging activity was expressed as the concentration of the sample required to reduce the absorbance of the control without addition of the sample to 1/2 as shown in Equation 2 below.

Figure 112013042140537-pat00002
Figure 112013042140537-pat00002

ABTS radical cation 소거능은 2,2-azino-bis(3-ethyl-benthiazoline-6-sulfonic acid) diammonium salt(ABTS)와 potassium persulfate와의 반응으로 ABTS+radical이 생성되면 특유의 색인 청록색을 띄게 되며 hydrogen danating antioxidant와 chain breaking antioxidant 모두를 측정할 수 있다. The ABTS radical cation scavenging activity of ABTS + radicals is due to the reaction of 2,2-azino-bis (3-ethyl-benthiazoline-6-sulfonic acid) diammonium salt (ABTS) with potassium persulfate. Both antioxidants and chain breaking antioxidants can be measured.

부평초의 ABTS radical 소거능 측정 결과를 도 2와 같이 나타내었다. 부평초 에탄올 추출물의 경우 10 μg/ml의 농도에서 36.7%로 열수 추출물보다 ABTS radical 소거능이 우수하였다. 부평초 에탄올 추출물의 용매별 분획물의 경우 EtOAC 분획물 10 μg/ml의 농도에서 44.2% 소거활성을 나타내어 분획물 중 가장 우수한 ABTS radical 소거능을 나타내었다.
The results of the measurement of ABTS radical scavenging ability of Bucheoncho were shown in Fig. In the case of Bukul Pyongcho ethanol extract, 36.7% at 10 μg / ml showed better ABTS radical scavenging ability than hot water extract. The fraction of the solvent fraction of Buchungchon ethanol extract showed 44.2% scavenging activity at the concentration of 10 μg / ml of EtOAC fraction and showed the best ABTS radical scavenging ability among the fractions.

실험예Experimental Example 2.  2. MTTMTT assayassay 에 의한 세포 Cells by 생존률Survival rate 측정 Measure

세포 생존률 측정은 Carmichael 등의 방법에 따라 측정하였다(Carmichael, J., W. G. DeGraff, A. F. Gazdar, J. D. Minna, and J. B. Mitchell. 1987. Evaluation of a tetrazolium based semiautomated colorimetric assay: assessment of chemosen- sitivity testing. Cancer Res . 47, 936-942.).
Cell viability was measured according to a method such as Carmichael (Carmichael, J., DeGraff WG, Gazdar AF, Minna JD, Mitchell JB and 1987. Evaluation of a tetrazolium based semiautomated colorimetric assay:.. Assessment of chemosen- sitivity testing Cancer Res . 47 , 936-942.).

2-1. 세포 배양2-1. Cell culture

B16F10 melanoma 세포는 Michikawa[Michikawa, M., K.T. Lim, J. G. McLarnon and S. U. Kim. 1994. Oxygen radical-induced neurotoxicity in spinal cord neuron cultures. J. Neurosci Res. 37, 62-70. 등의 방법에 따라 배양 세포에 0.25% 트립신(trypsin) 용액을 희석 처리한 후 세포를 분리한 다음 Dulbeco's modified eagle’s medium (DMEM) 배지에 10% fetal bovine serum (FBS)과 1% 페니실린/스트렙토마이신(penicillin/streptomycin) (100U/ml)을 첨가하여 37℃, 5% CO2 incubator에 적응시켜 배양하였다.
B16F10 melanoma cells were obtained from Michikawa [Michikawa, M., KT Lim, JG McLarnon and SU Kim. 1994. Oxygen radical-induced neurotoxicity in spinal cord neuron cultures. J. Neurosci Res. 37, 62-70. The culture broth was incubated with 10% fetal bovine serum (FBS) and 1% penicillin / streptomycin (DMEM) supplemented with Dulbecco's modified eagle's medium penicillin / streptomycin) (100 U / ml) was added and incubated at 37 ° C in a 5% CO 2 incubator.

2-2. 세포생존률 측정2-2. Cell viability measurement

각 세포주[melanoma (B16F10), fibroblast (CCD-986sk)]을 96 well plate에 0.6~8×103cells/well이 되게 0.18ml 분주하고, 시료를 농도 별로 조제하여 0.02ml 첨가한 후 37℃, 5% CO2 incubator에서 24시간 배양하였다. 대조군은 시료와 동량의 증류수를 첨가하여 동일한 조건으로 배양하였다. 여기에 5mg/ml 농도로 제조한 MTT 용액 0.02ml를 첨가하여 4시간 배양한 후 배양액을 제거하고 각 well당 DMSO:ethanol(1:1) 0.15ml를 가하여 실온에서 30분간 반응 시킨 뒤 ELISA reader로 550nm에서 흡광도를 측정하였다.Each cell line [melanoma (B16F10), fibroblast (CCD-986sk)] was dispensed in a 96-well plate at a concentration of 0.6 to 8 × 10 3 cells / well in an amount of 0.18 ml, and 0.02 ml was added to each sample. And cultured in a 5% CO 2 incubator for 24 hours. In the control group, the same amount of distilled water as that of the sample was added and the cells were cultured under the same conditions. After adding 0.02 ml of MTT solution (5 mg / ml) for 4 hours, the culture medium was removed. 0.15 ml of DMSO: ethanol (1: 1) was added to each well and reacted at room temperature for 30 minutes. Absorbance was measured at 550 nm.

CCD986sk 세포에 대한 부평초의 세포 생존율을 측정한 결과, 대조군에 비해 부평초 에탄올, 열수 추출물과 용매별 분획물은 25 μg/ml의 농도에서 80% 이상의 세포생존율을 나타내었다(도 3, 4). 부평초 에탄올, 열수 추출물과 용매별 분획물은 세포생존율 결과를 바탕으로 25 μg/ml의 농도에서 procollagen 생합성능과 MMP-1 활성을 검증 하였다.
As a result of measuring the cell survival rate of CCD986sk cells, supernatant ethanol, hot water extract and solvent fraction showed cell survival rate of 80% or more at a concentration of 25 μg / ml (FIGS. 3 and 4). Based on the cell viability results, Puccio ethanol, hot-water extract and solvent fractions were tested for procollagen biosynthesis and MMP-1 activity at a concentration of 25 μg / ml.

실험예 3. 주름 개선 효능 실험EXPERIMENTAL EXAMPLE 3 Experiment of wrinkle-improving effect

3-1. 엘라스타제(Elastase) 저해활성 측정3-1. Measurement of Elastase Inhibitory Activity

실시예에서 얻은 시료들의 엘라스타제 (Elastase) 저해활성을 시험하기 위하여 카넬 (Cannell) 등을 응용하여 하기와 같이 실험하였다(Cannell RJP, Kellan SJ, Owsianks AM and Walker JM. (1988) Results of a large scale screen of microalgae for the production of protease inhibitors. Planta Media. 54(1), 10-14.)(Cannell RJP, Kellan SJ, Owsians AM and Walker JM. (1988) Results of a (a) Test for the Elastase Inhibitory Activity of the Samples of the Examples large scale screen of microalgae for the production of protease inhibitors. Planta Media . 54 (1), 10-14.)

기질로서 N-succinyl-(L-Ala)3-Aster glehni-nitroanilide를 사용하여 37℃에서 20분간 기질로부터 생성되는 Aster glehni -nitroanilide의 생성량을 405nm에서 측정하였다. 즉, 각 시험용액을 일정 농도가 되도록 조제하여 0.5mL씩 시험관에 취하고, 50mM tris-HCl buffer (pH 8.6)에 녹인 porcine pancreas elastase (2.5U/mL, Sigma Chemical Co) 용액 0.5mL을 가한 후 기질로 50mM tris-HCl buffer (pH 8.6)에 녹인 N-succinyl-(L-Ala)3-Aster glehni -nitroanilide (0.5mg/mL)을 첨가하여 20분간 반응시켜 측정하였다. 엘라스타제 (Elastase) 저해활성은 하기 수학식 3과 같이, 시료용액의 첨가구와 무첨가구의 흡광도 감소율로 나타내었다. N-succinyl- (L-Ala) 3-Aster glehni-nitroanilide was used as a substrate and the amount of Aster glehni-nitroanilide produced from the substrate at 37 ° C for 20 minutes was measured at 405 nm. In other words, prepare each test solution to a constant concentration, take 0.5 mL each in a test tube, add 0.5 mL of porcine pancreas elastase (2.5 U / mL, Sigma Chemical Co) dissolved in 50 mM tris-HCl buffer (pH 8.6) N-succinyl- (L-Ala) 3-Aster glehni-nitroanilide (0.5 mg / mL) dissolved in 50 mM tris-HCl buffer (pH 8.6) Elastase inhibitory activity was represented by the absorbance decreasing rate of the addition solution of the sample solution and the non-addition solution as shown in the following equation (3).

Figure 112013042140537-pat00003
Figure 112013042140537-pat00003

이러한 본 실험 결과, 주름 생성과 관련된 elastase 저해 활성을 측정한 결과는 도 5과 같이 나타내었다. 부평초 에탄올의 경우 1,000 μg/ml의 농도에서 27.3%로 열수 추출물(7.2%)보다 elastase 저해효능을 나타내었다. 분획물의 경우 1,000 μg/ml의 농도에서 28.5%로 EtOAC 분획물이 가장 우수하였다.
As a result of this experiment, elastase inhibitory activity related to wrinkle formation was measured as shown in FIG. In the case of Bukul Pyongcho ethanol, the inhibitory effect of elastase was higher than that of the hot water extract (7.2%) at the concentration of 1,000 μg / ml of 27.3%. The fraction of EtOAC fraction was the best at 28.5% at the concentration of 1,000 μg / ml.

2-2. 2-2. 콜라게나제Collagenase 저해활성 측정 Measurement of inhibitory activity

실시예에서 얻은 시료들의 콜라게나제(collagenase) 저해활성을 시험하기 위하여 문헌에 기재된 W등의 방법을 응용하여 하기와 같이 실험하였다(WE and Heindrich HG. (1963) Zur quantitativen bestimmung der collagenase. Hoppe-Seyler's. Physiol . Chem. 333:149-151.)
In order to test the collagenase inhibitory activity of the samples obtained in the examples, the following experiment was carried out by applying the method described in the literature (WE and Heindrich HG. (1963) Zur quantitativen bestimmung der collagenase. Hoppe- Seyler's. Physiol . Chem . 333: 149-151.)

즉 반응구는 0.1M tris-HCl buffer (pH 7.5)에 4mM CaCl2를 첨가하여, 4-phenylazo benzyloxycarbonyl-Pro-Leu- Gly-Pro-D-Arg (0.3 mg/ml)를 녹인 기질액 0.25ml 및 시료용액 0.1ml의 혼합액에 collagenase (0.2 mg/ml) 0.15ml를 첨가하여 실온에서 20분간 방치한 후 6% citric acid 0.5ml을 넣어 반응을 정지 시킨 후, ethyl acetate 1.5ml을 첨가하여 320nm에서 흡광도를 측정하였다. Collagenase 저해활성은 하기 수학식 4과 같이, 시료용액의 첨가구와 무첨가구의 흡광도 감소율로 나타내었다.Specifically, 0.25 ml of a substrate solution prepared by adding 4 mM CaCl 2 to 0.1 M tris-HCl buffer (pH 7.5) and dissolving 4-phenylazo benzyloxycarbonyl-Pro-Leu-Gly-Pro-D-Arg 0.1 ml of collagenase (0.2 mg / ml) was added to the mixture. After incubation at room temperature for 20 minutes, 0.5 ml of 6% citric acid was added to stop the reaction, and 1.5 ml of ethyl acetate was added thereto. Were measured. The collagenase inhibitory activity was expressed by the absorbance decreasing rate of the addition solution of the sample solution and the non-addition solution as shown in the following equation (4).

Figure 112013042140537-pat00004
Figure 112013042140537-pat00004

부평초의 열수, 에탄올 추출물 및 용매별 분획물의 collagenase 저해활성을 측정하였다(도 6). 측정 결과, 1,000 μg/ml의 농도에서 에탄올 추출물 83.8%, 열수 추출물 77.2%의 collagenase 저해활성을 나타내었다. 또한, EtOAC 분획물은 1,000 μg/ml의 농도에서 84.3%의 collagenase 저해활성을 나타내어 분획물 중 가장 우수하였다.
The collagenase inhibitory activity of hydrothermal, ethanol extracts and solvent fractions of Bucheoncho was measured (Fig. 6). As a result of the measurement, the ethanol extract showed a collagenase inhibitory activity of 83.8% and the hot water extract of 77.2% at a concentration of 1,000 μg / ml. In addition, the EtOAC fraction showed the highest inhibition of collagenase activity by 84.3% at a concentration of 1,000 μg / ml.

2-3. 프로-콜라겐 생합성 측정2-3. Pro-collagen biosynthesis assay

실시예에서 얻은 시료들의 프로-콜라겐(pro-collagen) 생합성에 미치는 영향을 시험하기 위하여 문헌에 기재된 방법을 응용하여 하기와 같이 실험하였다 (Kim MJ, Kim JY, Choi SW, Hong JT and Yoon KS. (2004) Anti-wrinkle effect of safflower (Cathamus tinctorius) seed extract. J. Soc . Cosmet . Scientisis Korea. 30(1), 15-22.).
In order to test the effect of the samples obtained in the examples on the pro-collagen biosynthesis, the following methods were applied to the methods described in the literature (Kim MJ, Kim JY, Choi SW, Hong JT and Yoon KS. (2004) Anti-wrinkle effect of safflower ( Cathamus tinctorius ) seed extract. J. Soc . Cosmet . Scientisis Korea. 30 (1), 15-22.).

CCD-986sk세포(ATCC)에 시료를 농도별로 처리했을 때 pro-collagen type Ⅰ의 합성양을 측정하기 위해 Procollagen Type-Ⅰ C-Peptide (PIP) EIA kit(#MK101)를 TAKARA Bio Inc. (Shiga, Japan)에서 구입하여 이용하였다. 96-well plate에 각 well당 5×104 cells/well세포가 되도록 12well plate에 접종한 후 24시간을 안정화 하였다. 이 후, 배양된 배지를 제거하고 시료 추출물을 농도별로 처리한 후 CO2 배양기에서 48시간을 배양하였다. 각 well로부터 상등액을 회수하여 procollagen Type-Ⅰ C-Peptide (PIP) EIA kit의 각 well에 첨가한 후, 제조사의 방법에 따라 procollagen type Ⅰ의 총 양을 측정 하였다. Procollagen Type-I C-Peptide (PIP) EIA kit (# MK101) was purchased from TAKARA Bio Inc. to measure the amount of pro-collagen type I synthesis when CCD-986sk cells (ATCC) (Shiga, Japan). The cells were inoculated on a 96-well plate at a density of 5 × 10 4 cells / well in a 12-well plate, and then stabilized for 24 hours. Thereafter, the cultured medium was removed, and the sample extracts were treated at different concentrations, followed by incubation for 48 hours in a CO 2 incubator. The supernatant from each well was recovered and added to each well of procollagen Type-I C-Peptide (PIP) EIA kit, and then the total amount of procollagen type I was measured according to the manufacturer's method.

섬유아세포에 대한 procollagen type Ⅰ C-peptide (PICP) enzyme immunoassay에 의한 collagen 생합성량을 측정한 결과, 도 7과 같이 나타내었다. 부평초 에탄올과 열수 추출물의 경우 25 μg/ml의 농도에서 각각 45.1%, 37.2%의 procollagen 생합성량이 나타내었다. 부평초의 용매별 분획물의 경우 EtOAC (57.2%) > BuOH (41.5%) > water (42.8%) > hexane (32.3%) 순으로 Procollagen 생합성 활성을 나타내었다.
The amount of collagen biosynthesis by procollagen type Ⅰ C-peptide (PICP) enzyme immunoassay for fibroblasts was measured and is shown in FIG. The amount of procollagen biosynthesis was 45.1% and 37.2% at the concentration of 25 μg / ml for Puchoncho ethanol and hot water extract, respectively. Bucolic acid fraction showed the activity of Procollagen biosynthesis in the order of EtOAC (57.2%)> BuOH (41.5%)> water (42.8%)> hexane (32.3%).

2-4. MMP-1 저해활성 측정2-4. Measurement of inhibitory activity of MMP-1

실시예에서 얻은 시료들의 MMP-1 저해활성을 시험하기 위하여 문헌에 기재된 방법을 응용하여 하기와 같이 실험하였다(Shim JS, Choi EJ, Lee CW, Kim HS and Hwang JK. (2009) Matrix metalloproteinase-1 inhibitory activity of Kaempferia pandurata Roxb. J of food. 12(3), 601-607.).
To test the MMP-1 inhibitory activity of the samples obtained in the Examples, the method described in the literature was applied as follows (Shim JS, Choi EJ, Lee CW, Kim HS and Hwang JK. (2009) Matrix metalloproteinase-1 inhibitory activity of Kaempferia pandurata Roxb. J of food 12 (3), 601-607.).

세포를 5x104 cells/well 농도로 12well plate에 접종한 후, 각 well에 시료를 첨가하여 CO2 배양기에서 48시간 배양하였다. 이때 MMP-1의 활성을 높이기 위하여 TNF-α를 10ng/mL의 농도로 첨가하였다. 세포의 배양액을 수거하여 matrix metalloproteinase-1 biotrack activity assay kit(R&D system, DMP100)을 이용하여 측정하였다. Cells were inoculated on a 12-well plate at a concentration of 5 × 10 4 cells / well, and samples were added to each well and cultured in a CO 2 incubator for 48 hours. At this time, TNF-α was added at a concentration of 10 ng / mL to increase the activity of MMP-1. Cell cultures were harvested and counted using the matrix metalloproteinase-1 biotrack activity assay kit (D & D system, DMP100).

부평초의 MMP-1 저해활성 측정 결과는 도 8과 같이 나타내었다. 그 결과, 부평초 에탄올 추출물의 경우 25 μg/ml의 농도에서 17.5%를 나타내어 물 추출물보다 효과가 우수하였다. EtOAC 분획물의 경우 대조군에 비해 31.7%의 저해율을 나타내어 분획물 중에서 MMP-1 저해활성이 가장 우수하였다.
The results of measurement of MMP-1 inhibitory activity of Buchungcho were shown in FIG. As a result, the ethanol extract of Buchungcho showed 17.5% at 25 μg / ml, which is more effective than the water extract. The EtOAC fraction showed an inhibition rate of 31.7% as compared with the control, and the MMP-1 inhibitory activity was the highest among the fractions.

실험예 4. 미백 활성 실험Experimental Example 4. Whitening activity test

4-1. 티로시나제 저해활성4-1. Tyrosinase inhibitory activity

실시예에서 얻은 시료들의 티로시나제 (Tyrosinase) 저해활성을 시험하기 위하여 문헌에 개시된 Yagi 등의 방법을 응용하여 하기와 같이 실험하였다 (Yagi A, Kanbara T and Morinobu N. (1986) The effect of tyrosinase inhibition for aloe. Planta Media. 3981, 517-519.)In order to test the tyrosinase inhibitory activity of the samples obtained in the examples, the following experiment was conducted by applying the method of Yagi et al. (Yagi A, Kanbara T and Morinobu N. (1986)) to the effect of tyrosinase inhibition aloe, Planta Media , 3981, 517-519.)

반응구는 0.175M sodium phosphate buffer(pH 6.8) 0.5mL에 10mM L-DOPA를 녹인 기질액 0.2mL 및 시료용액 0.1mL의 혼합액에 버섯 티로시나제 (mushroom tyrosinase; 110U/mL) 0.2mL을 첨가하여 25℃에서 2분간 반응시켜 반응액 중에 생성된 DOPA chrome을 475nm에서 측정하였다. 티로시나제 (Tyrosinase) 저해활성은 하기 수학식 5와 같이, 시료용액의 첨가구와 무첨가구의 흡광도 감소율로 나타내었다.To the reaction mixture, 0.2 mL of mushroom tyrosinase (110 U / mL) was added to a mixture of 0.2 mL of the substrate solution in which 10 mM L-DOPA was dissolved in 0.5 mL of 0.175 M sodium phosphate buffer (pH 6.8) and 0.1 mL of the sample solution, DOPA chrome produced in the reaction solution was measured at 475 nm for 2 minutes. The tyrosinase inhibitory activity was expressed by the absorbance decreasing rate of the addition solution of the sample solution and the non-addition solution as shown in the following equation (5).

Figure 112013042140537-pat00005
Figure 112013042140537-pat00005

본 실험 결과, 피부 내에서 멜라닌 중합체 생합성을 효과적으로 저해할 수 있는 tyrosinase 저해활성을 측정하기 위하여 mushroom유래의 tyrosinase 저해 활성 측정 결과는 도 9과 같이 나타내었다. 측정한 결과, 부평초 에탄올 추출물의 경우 1,000 μg/ml의 농도에서 25.8%의 저해율을 나타내었고, 물추출물의 경우 8.7%의 저해율을 나타내었다. 용매 분획물 중에서는 EtOAC 분획물의 경우 1,000 μg/ml의 농도에서 38.2%의 저해율을 나타내어 tyrosinase 저해효과가 가장 우수하였다.
As a result, the tyrosinase-inhibiting activity of mushroom-derived tyrosinase inhibitory activity, which can effectively inhibit melanin polymer biosynthesis in the skin, is shown in FIG. As a result, the inhibition rate of Bu Puiljia ethanol extract was 25.8% at the concentration of 1,000 μg / ml and 8.7% of the water extract. Among the solvent fractions, the EtOAC fraction showed the inhibition rate of 38.2% at the concentration of 1,000 μg / ml, showing the most excellent tyrosinase inhibitory effect.

4-2. 멜라닌(4-2. Melanin ( melaninmelanin ) 생합성 저해율) Biosynthesis inhibition rate

실시예에서 얻은 시료들의 피부 멜라노마 세포로부터의 멜라닌(melanin) 생합성 저해 활성을 시험하기 위하여 Hosoi 등의 문헌에 개시된 Melanoma cell(B16F10)에서의 멜라닌(melanin) 생합성 저해율 측정 방법을 응용하여 하기와 같이 실험하였다(Hosoi J. Abe E, Suda T and Kuroki T. (1985) Regulation of melanin synthesis of B16 mouse melanoma cells by 1 alpha, 25-dihydroxyvitamin D3 and retinoic acid. Cancer Res. 45(4), 1474-1478. )
In order to test the melanin biosynthesis inhibitory activity of skin melanoma cells of the samples obtained in the examples, a method of measuring the inhibition rate of melanin biosynthesis in Melanoma cell (B16F10) disclosed in Hosoi et al. (Hosoi J. Abe E, Suda T and Kuroki T. (1985) Regulation of melanin synthesis of B16 mouse melanoma cells by 1 alpha, 25-dihydroxyvitamin D3 and retinoic acid. Cancer Res 45 (4), 1474-1478 .)

DMEM 배지로 배양된 멜라노마 세포를 100mm culture dish에 2×106cell/dish가 되게 분주하고, 24시간 배양 후 시료를 농도별로 조제하여 2 ml 첨가하고, 48시간 후에 인산완충액 (pH 7.4)으로 세척하였다. 그 다음 0.25M trypsin-EDTA 용액으로 세포를 탈착한 후 수확한 세포를 1×106세포 당 1ml의 5% TCA로 처리하고, 2,500rpm으로 2회 원심분리한 후 분리된 melanin을 인산완충액으로 세척한 뒤 ether:ethanol(1:3) 1ml를 가하여 2회 원심분리 한 후 ether 1ml로 세척 건조시킨다. 건조된 melanin에 1N NaOH를 1ml 가하여 80℃에서 1시간 반응시킨 후 분광 광도계 405nm에서 흡광도를 측정하였다. Melanin 생합성 저해는 하기 수학식 6과 같이, 시료용액의 첨가구와 무첨가구의 흡광도 감소율로 나타내었다.The melanoma cells cultured in the DMEM medium were divided into 2 × 10 6 cells / dish in a 100 mm culture dish. After culturing for 24 hours, 2 ml of the sample was prepared by concentration, and after 48 hours, the cells were incubated with phosphate buffer (pH 7.4) And washed. The cells were then desalted with 0.25 M trypsin-EDTA solution, and the harvested cells were treated with 1 ml of 5% TCA per 1 × 10 6 cells, centrifuged twice at 2,500 rpm, and the separated melanin was washed with phosphate buffer After that, 1 ml of ether: ethanol (1: 3) is added, centrifuged twice, and washed with 1 ml of ether. 1 ml of 1N NaOH was added to the dried melanin, reacted at 80 ° C for 1 hour, and the absorbance was measured at 405 nm by a spectrophotometer. The inhibition of melanin biosynthesis was expressed by the absorbance decreasing rate of the addition solution of the sample solution and the non-addition solution as shown in the following equation (6).

Figure 112013042140537-pat00006
Figure 112013042140537-pat00006

추출물의 melanoma 세포에서의 멜라닌 생합성을 측정한 결과는 부평초 에탄올, 열수 추출물과 용매별 분획물에 의한 melanoma 세포의 생존율을 확인한 결과 도 10와 같이 대조군에 비해 25 μg/ml의 농도에서 모두 80% 이상의 생존율이 나타났다.
Melanin biosynthesis in the extract of melanoma cells was examined. The survival rate of melanoma cells by Puchoncho ethanol, hot water extract and fraction of solvent was examined. As a result, the survival rate of melanoma cells was 80% or more at 25 μg / .

4-3. 세포내 티로시나제 저해활성4-3. Intracellular tyrosinase inhibitory activity

실시예에서 얻은 시료들의 세포내 티로시나제(Cellular tyrosinase) 저해활성을 시험하기 위하여 문헌에 개시된 Choi 등의 방법을 응용하여 하기와 같이 실험하였다(Choi BW, Lee BH, Kang KJ, Lee ES and Lee NH. (1998) Screening of the tyrosinase inhibitors from marine algae and medicinal plants. Kor . J. Pharmacogn. 29(3), 237-242. )
In order to test the cellular tyrosinase inhibitory activity of the samples obtained in the examples, Choi et al. (1995) and Choi et al. (1998) Screening of the tyrosinase inhibitors from marine algae and medicinal plants Kor . J. Pharmacogn . 29 (3), 237-242.)

B16F10 melanoma 세포(ATCC)를 6 well에 5×104 cell이 되도록 접종하여 배양하고, 24시간 뒤 각 well에 시료를 48시간 동안 처리한다. 처리 후 PBS로 2회 세척한 후 각 well의 세포에 lysis buffer (1% triton X-100, 0.1M Sodium phosphate buffer, 50mM PMSF, pH 6.8)를 가하였다. 얼음 위에서 세포를 파괴시키고 원심 분리한 후 상층액만 따로 모아 효소용액으로 사용하였다. L-DOPA를 2mg/mL 농도로 0.1M sodium phosphate buffer (pH 6.8)에 녹여 기질을 준비하고 기질 160μL에 효소용액 40μL를 가하고 37℃에서 1시간 가온하고 생성된 DOPA chrome의 양을 490nm에서 측정한 후 (1-시료의 흡광도/대조구의 흡광도)×100 에 의하여 억제율을 계산하였다.
B16F10 melanoma cells (ATCC) were inoculated in 6 × 5 × 10 4 cells and cultured for 24 hours. Each sample was treated for 48 hours. After washing with PBS twice, lysis buffer (1% triton X-100, 0.1M sodium phosphate buffer, 50 mM PMSF, pH 6.8) was added to each well. Cells were disrupted on ice and centrifuged, and only the supernatant was collected and used as the enzyme solution. L-DOPA was dissolved in 0.1 M sodium phosphate buffer (pH 6.8) at a concentration of 2 mg / mL to prepare a substrate. The enzyme solution (40 μL) was added to 160 μL of the substrate and incubated at 37 ° C. for 1 hour. The amount of DOPA chrome produced was measured at 490 nm (1-absorbance of the sample / absorbance of the control) × 100.

본 실험 결과, 부평초 에탄올, 열수 추출물의 melanin 생합성 저해활성을 측정한 결과는 도 11과 같이 나타내었다. 부평초 에탄올과 열수 추출물의 경우 25 μg/ml의 농도에서 각각 9.6%, 0.8%의 저해활성을 나타내었다. 분획물의 경우 EtOAC 분획물이 16.5%로 melanin 생합성 저해활성이 가장 우수하였다.
As a result, the inhibitory activity against melanin biosynthesis of Puchoncho ethanol and hot water extract was measured as shown in FIG. The concentration of 25 μg / ml of Buchyeongcho ethanol and hot water extracts showed inhibitory activity of 9.6% and 0.8%, respectively. The fractions of EtOAC fraction showed 16.5% inhibition of melanin biosynthesis.

이하, 본 발명의 제형예로서 크림, 맛사지크림, 로션, 스킨로션, 에센스, 팩, 클렌징폼의 제형을 예시하고 있으나, 본 발명의 화장품 조성물을 포함하는 제형은 이에 한정되는 것은 아니다.
Hereinafter, formulations of cream, massage cream, lotion, skin lotion, essence, pack, and cleansing foam are exemplified as the formulation examples of the present invention, but the formulations including the cosmetic composition of the present invention are not limited thereto.

제형예Formulation Example 1. 크림조성물 1. Cream composition

유상과 수상을 각각 75 ℃로 가열 혼합한 후 실온으로 냉각한다.The oil phase and water phase are heated to 75 ° C and cooled to room temperature.

Figure 112013042140537-pat00007
Figure 112013042140537-pat00007

제형예Formulation Example 2.  2. 맛사지크림Massage Cream 조성물 Composition

유상과 수상을 각각 75 ℃로 가열 용해 혼합한 후 실온으로 냉각한다.The oil phase and water phase are mixed by heating at 75 DEG C and then cooled to room temperature.

Figure 112013042140537-pat00008
Figure 112013042140537-pat00008

제형예Formulation Example 3. 로션 조성물 3. lotion composition

유상과 수상을 각각 75 ℃로 가열 혼합 유화한 후 실온으로 냉각한다.The oil phase and water phase are mixed and emulsified by heating at 75 ° C and then cooled to room temperature.

Figure 112013042140537-pat00009
Figure 112013042140537-pat00009

제형예 4. 스킨로션 조성물Formulation Example 4. Skin lotion composition

수상과 에탄올상을 각각 제조 혼합한 후 여과한다.The water phase and the ethanol phase are respectively prepared and mixed and then filtered.

Figure 112013042140537-pat00010
Figure 112013042140537-pat00010

제형예Formulation Example 5. 에센스 조성물 5. Essence composition

수상과 에탄올상을 각각 제조 혼합한 후 여과한다.The water phase and the ethanol phase are respectively prepared and mixed and then filtered.

Figure 112013042140537-pat00011
Figure 112013042140537-pat00011

제형예Formulation Example 6. 팩 조성물 6. Pack composition

수상과 에탄올상을 각각 분산 용해하여 혼합시킨 후 실온으로 냉각한다.The water phase and the ethanol phase are dispersively dissolved and mixed, and then cooled to room temperature.

Figure 112013042140537-pat00012
Figure 112013042140537-pat00012

제형예Formulation Example 7.  7. 클렌징폼Cleansing Foam 조성물 Composition

수상과 오일상을 각각 분산 용해하여 혼합 검화한 후 실온으로 냉각한다.The water phase and the oil phase are dispersed and dissolved, mixed and sieved, and then cooled to room temperature.

Figure 112013042140537-pat00013
Figure 112013042140537-pat00013

Claims (8)

부평초 에탄올 추출물의 에틸아세테이트 분획물을 유효성분으로 함유하는 미백 및 피부노화의 치료 및 예방용 피부외용 약학조성물.A skin pharmaceutical composition for treating and preventing whitening and skin aging comprising an ethyl acetate fraction of Puchoncho ethanol extract as an active ingredient. 삭제delete 삭제delete 삭제delete 삭제delete 제 1항에 있어서, 상기 약학 조성물은 크림, 젤, 패취, 분무제, 연고제, 경고제, 로션제, 리니멘트제, 파스타제 또는 카타플라스마제 제형인 것을 특징으로 하는 피부외용 약학조성물.The dermatological pharmaceutical composition according to claim 1, wherein the pharmaceutical composition is a cream, a gel, a patch, a spray, an ointment, a warning agent, a lotion, a liniment, a pasta or a cataplasma. 부평초 에탄올 추출물의 에틸아세테이트 분획물을 유효성분으로 함유하는 미백 및 피부노화의 개선 및 예방용 화장료 조성물.A cosmetic composition for improving and preventing whitening and skin aging comprising an ethyl acetate fraction of an ethanol extract of Buchung - 제 7항에 있어서 상기 화장료 조성물은 화장수, 스킨, 로션, 영양로션, 영양크림, 마사지 크림, 에센스, 팩의 제형인 것을 특징으로 하는 화장료 조성물.The cosmetic composition according to claim 7, wherein the cosmetic composition is a formulation of lotion, skin, lotion, nutrition lotion, nutritional cream, massage cream, essence, pack.
KR1020130053986A 2013-05-13 2013-05-13 Skin whitening composition comprising complex herbal extract KR101499453B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020130053986A KR101499453B1 (en) 2013-05-13 2013-05-13 Skin whitening composition comprising complex herbal extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020130053986A KR101499453B1 (en) 2013-05-13 2013-05-13 Skin whitening composition comprising complex herbal extract

Publications (2)

Publication Number Publication Date
KR20140134175A KR20140134175A (en) 2014-11-21
KR101499453B1 true KR101499453B1 (en) 2015-03-06

Family

ID=52455388

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020130053986A KR101499453B1 (en) 2013-05-13 2013-05-13 Skin whitening composition comprising complex herbal extract

Country Status (1)

Country Link
KR (1) KR101499453B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190108811A (en) 2018-03-15 2019-09-25 에스케이바이오랜드 주식회사 Cosmetic composition comprising extract of Spirodela polyrhiza for improvement of skin damage or skin-protection
KR20240068810A (en) 2022-11-01 2024-05-20 주식회사 코루파마 A novel polypeptide with prevention, improvement or treatment function of skin aging

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08175957A (en) * 1994-12-27 1996-07-09 Kao Corp Skin agent for external use
JP2007126368A (en) * 2005-11-01 2007-05-24 Shiseido Co Ltd Antiaging agent, collagenase inhibitor and antioxidant
KR100975078B1 (en) * 2008-03-14 2010-08-11 한불화장품주식회사 A Cosmetic composition containing Azolla imbricata extract
KR20110083813A (en) * 2010-01-15 2011-07-21 주식회사 알엔에스 Cosmetic composition having anti oxidant activity

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08175957A (en) * 1994-12-27 1996-07-09 Kao Corp Skin agent for external use
JP2007126368A (en) * 2005-11-01 2007-05-24 Shiseido Co Ltd Antiaging agent, collagenase inhibitor and antioxidant
KR100975078B1 (en) * 2008-03-14 2010-08-11 한불화장품주식회사 A Cosmetic composition containing Azolla imbricata extract
KR20110083813A (en) * 2010-01-15 2011-07-21 주식회사 알엔에스 Cosmetic composition having anti oxidant activity

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190108811A (en) 2018-03-15 2019-09-25 에스케이바이오랜드 주식회사 Cosmetic composition comprising extract of Spirodela polyrhiza for improvement of skin damage or skin-protection
KR20240068810A (en) 2022-11-01 2024-05-20 주식회사 코루파마 A novel polypeptide with prevention, improvement or treatment function of skin aging

Also Published As

Publication number Publication date
KR20140134175A (en) 2014-11-21

Similar Documents

Publication Publication Date Title
KR101513892B1 (en) A Method for producing a purified extract containing abundant amoun of tanshinone I and tanshinone IIA showing anti-oxidative activity, skin whitening activity and anti-wrinkle activity from Salvia miltiorrhiza BUNGE
KR100828193B1 (en) Composition comprising an extract of nelumbo nucifera gaertner showing skin whitening, anti-aging and anti-wrinkle activity
KR101510092B1 (en) A composition comprising the seed extract of Rubus coreanus M for preventing and treating skin aging and for skin whitening
KR101086736B1 (en) Composition comprising a crude complex herb extract showing anti-aging and anti-wrinkle activity
KR20140056487A (en) A topical composition comprising the extract of persimmon calyx or trifolin isolated therefrom as an active ingredient for preventing and treating skin wrinkle and for skin-whitening
KR101143820B1 (en) Cosmetic composition comprising an extract of Aster ageratoides Turcz. var. ageratoides having whitening activities
KR20100094614A (en) Cosmetic composition comprising an extract of black garlic having skin whitening and wrinkle improving activity
KR101954773B1 (en) The purification method for effectively isolating abundant active ingredient form larch tree by-products and the composition comprising the same
KR101749669B1 (en) Topical composition comprising the isolated compounds from Rubus coreanus seed showing skin whitening effect
KR101243219B1 (en) Skin whitening and anti-wrinkle composition comprising a fermented plant extract in Ulleung island
KR20160121074A (en) A composition comprising an seed extract of Vitex trifolia L. for skin whitening and anti-aging activity
KR101774867B1 (en) A Cosmetic Composition for Whitening or Pore-Minimizing Comprising Extract of cone scale of Pinus koraiensis Siebold et Zucc
KR101499453B1 (en) Skin whitening composition comprising complex herbal extract
KR101458013B1 (en) Composition for anti-oxidation and whitening and anti-wrinkle cosmetics comprising extract of un-ripening Pinus koraiensis Siebold et Zucc cone
KR101685121B1 (en) Skin composition comprising the purified extract of fermented chestnut bur showing anti-aging or anti-inflammatory activity
KR20120036011A (en) Composition comprising a leaf extract of isatis tinctoria l. showing skin whitening and anti-wrinkle activity
KR20140116666A (en) Skin whitening and anti-skin aging composition comprising complex herbal extract
KR101541842B1 (en) Skin composition comprising the extract of fermented chestnut bur showing skin whitening and anti-aging or anti-inflammatory activity
KR101646347B1 (en) Anti-oxidant and skin whitening composition comprising a pine cone extract
KR101873244B1 (en) Skin composition comprising the sprouting seed extract of Schisandra chinensis for anti-wrinkle or anti-inflammatory activity
KR20140004330A (en) A composition comprising the compound isolated from fructus extract of arctium luppa l for preventing and treating wrinkle
KR101570123B1 (en) Cosmetic Composition Comprising Extract of testa of Pinus koraiensis Siebold et Zucc
KR20140117003A (en) A composition comprising the phenolic compounds isolated from extract of Carthamus tinctorious seeds as an active ingredient for skin whitening
KR20140033609A (en) A composition comprising the compounds isolated from extract of carthamus tinctorious seeds as an active ingredient for preventing and treating skin aging related disease
KR100614467B1 (en) Cosmetic composition comprising the extract mixture of euphorbia helioscopia l., paeonia suffruticosa andr. and aloe vera l. having inhibition activity of melanin synthesis

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20180302

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20200302

Year of fee payment: 6